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Dated ___________ J~u~n~e~l~4~,~1~9~7_7 ____________ __ 
Dedicated in loving memory of my 
mother who taught me that the odds 
in this world are not against me. 
ii 
SEllSORY NERVE ACTIVITY IN THE RAT 
FOLLOWING INDUCED-SWELLING AND INFLAMMATION 
ABSTRACT OF DISSERTATION 
Pain is one of the cardinal sigris of' inf'Jnnirnation, but.1ts 
production during the inflammatory procass has been tX>orly delineated. 
While analgesic and antiedema activities have been well studied in the 
11 terature, miurogrem studies of nerves diri!ctly involved with local in-
flammation have not been re rted to nate. 
One purpose 4f this inve~tigatlon was io determine if dir~ 
ferences iri nourogram patterns were apparent using different phlogistic 
agents and electrophyslologlcal recording of the inflammation-induced 
"pain... Tho tibiotarsal nerve of the left hind paw of male rats was 
isolated under urethan anesthesia for in vivo recording. Electrodes . 
were placed ori the nerve. ,and neurogram'S recorded. Subplantar injections 
llere made in the left hirid paw with the following• saline control (0.9%, 
o.os ml.), carrageenin (1%, o.os ml.), dextran (1%, 0.05 ml.) and brew-
er's yeast (.5%, 0.10 ml.). In three-hour recordings, the :{'Oak neural 
o.otivity was reached at +120 minutes (yeast), +90 minutes {dextran) and 
+JO, 60 and 1.50 minutes (carrageenin'.s three peaks). Dextran had the 
weakest hyperalgesic aoti vi ty while brewer's yeast and carrageenin had 
comparable degrees of hyperalgesia •. No phlogistic activity and no 
change in neurogram patterns were seen in the saline control animal¢. 
ln parallel studies measuring pedal edema, carrageenin appeared sign1f-
1oantly more active thBn bi::ewer's yeast as an inflammogen while dextran 
demonstra·ted a complete .lack or phlogistic ncti v1 ty, 
, The second }lha~e of this,ih\lestigat!on lias to stUdy neUtogi'alft 
i'IHJ()l."dings obtained in iui1mala receiving orally administered prototyjle 
ilnti-in:Clammatory agents or chlorpl.'Oifl9.!11111e one hour before cl\rrageenln 
liO.ti in,looted pedl,\lly, Dosages (10 mlo/kg,) lltti'O thOfJII shown to be liqul" 
'Valotrt 1n reducing oart'ilSOiln\n.,.induced j>edlll ethma. Jlenults ind1caied 
t.ho.t qhlo:rp:romatline (1flf;i mg./kg.) had the 1oilel3t no\IX'al activity (niltlit · 
1;\t +taU minu·tes) while animals Jli'Ot.rOIIt.i.ld 111 th h;ydrooortiaonn (20 lflg•/ 
kg,) demonstrated 60ine h.YJX~ralgaaiu 90 .minuwu at'tor the podlll injection; 
l'hiinylbut.a~ono (100 mgo/k~,, ne.d11• at +60 minutos) 1 indometh,. Oin (10 rng./ 
~~~., nMJ.r at +6o mlnut.oa} and aoe·~ylFJalioylic o.o1d (:300 mg; kg, 1 natl~r. , 
at +90 minutes) hwl a deereM1ng o~"dot of hyp!lritlJ3eato activity, Aftii.ly• 
sis \'l:C val'iance ilas pej~ormed between plothya~i'lgra.phio and mlittogram 
atUd1os.1n control (0,2~ agar dosing vohiolo} o.nd the ant1~1nf1ammatoxt­
p:rotNated animalo. Thlltll was sign1fiolllit parllllel 1'1llat1onships (ef.. ' 
fiilit/maximum effect) Ui ll.gar contl'(>l_Md hydroclorttrmne-pretl'Cated !ii'li-
11!1\1!1 11horeao the otMr treabnonta did not ell:h1t:.it Jli!l:-n:UeUam botwu~ll 
thll edematoun :l'oX'Iiii\Uolt e.nd now:og~nio illt1amm!l.t.ol1' litud1es. It is 
pctltulated that antidrolll1ci 1nvaslot1 ·of cheMical mudiators may play an 
1mpo:ttant l'Ole in neurilQenic 1nflnmnia~llon (pain) and that edema for!lla• 
t1on ie a consequence ot prinolples mloaacd upon lysiB of phtlgocytea, 
'the h;yperalgesfc actiVity 111ay be a rellUlt of tho rslEII\tJe of k1n1ns f:t'Om 
pl.atJnm substrate 1nto Ule inflammatory exudate 1n tho presence of loti 
concentrations of prostaglandins (E type), Aap1r1n and indomothacin are 
ltnolln to 1nh1b1 t the biosynthesis Of prostaglalldiue, Xt is' euapeoted 
that phimylbutazono and chlorpromazine may act in U1o same manner but 
•uothor chemical mediator may be responsible for tho low neurogram Mtiv~ 
ity associated with thelle agents, · 
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Heat and pain, along wi·th redness and swelling, 
have been distinguished as the primary diagnostic marks of 
inflammation since ·the second century, A. D. ( 1). A fifth 
Induced erythema (redness) and edema {swelling) have been 
widely used experimentally by pharmacologists searching 
for new anti-inflammatory drugs. For many ·types of ar·th-
r.itis, where inflammation is one of the manifestations, pain 
h; the major symptom and is frequently the cauGe of crippling 
disability. It is, therefore, surprising that the pain 
thrc~shold in inflammation has not been vmll exi:.lmined neuro-
logically. 
It is known that the severity of pain varies from 
one patient to another. A report by Huskisson has indicated 
that there is no compelling evidence that pain threshold 
affects the course of rheumatoid arthritis in any way (2}; 
this research was based on a method used by Keele where an 
a.lgometer was employed ( 3} • The findings revealed that 
patients with a low pain threshold had pain lasting longer 
which, .in turn, necessi. ta.ted an increased usage of anal·-
gesics. In another type of arthritis, ankylosing spondy-
litis, the pain threshold was higher and the requirements 
1 
2 
for analgesics were less. 
Inflammation is the common final pathway for a 
variety of processes, '\'lhich arise from intrusion of certain 
organisms or foreign molecules into the body. Inflarnn1ation 
causes local tissue alterations, destruction and scarring, 
and often the initial site becomes the target for recurrent 
assaults (4). The important regulatory proper-ty of the 
l-------'--~in£la.mmaJ:or_y_p_roc._e_g_s-..i..s-hom-eg-s-t-a-s-i--s-. ~'I!e-E1-e-f~i..-I-re-t;-h-i-s-,-e-n-e:·-------
can say that inflammation is a protective mechanism in the 
body whereby noxious stimuli are neutralized and the sur-
rounding tissue, damaged by the noxious stimuli, is repaired. 
As in other homeostatic mechanisms, the control of the 
inflammatory process can be lost and cause more harm than 
the original injury, i.e. when the physiological steady-
state of homeostasis has been then lost. Thus, the acute 
. 
inflammatory reaction can be classified as a "true" homeo-
stasis while recurrent or chronic inflammation associated 
with loss of tissue function may be characterized as a 
disease process. Since the pain of acute inflammation is 
the primary interest of the:present study, chronic inflam-
mation will not be discussed. 
Mechanism of Inflammation. Weissman (5) has stated that 
there a.re five general pathways or mechanisms to acute 
.inflammation: (;!:) cellular release (cells that respond 
to injury), (ii) fluid--phase activation (mediators formed 
by cleavage of precursor substrates in fluid), {~ii) bypass 
3 
mechanisms (those bypassing the previous mechanism) , (!_y) 
extracellular control loops, and (~).intracellular loops. 
The last two involve a Yin-Yang hypothesis with the regu-
lation of the mediator release controlled by the secretion 
of cAMP and cGMP. The reputed mediators involved are listed 
and classified in Table I. The first four mediators, the 
inm1ediators, appear early in inflammation whereas the comple-
ment and lysosomal enzymes appear in the latter phase of 
the inflammatory process along 1vi th lymphokines. Both 
Hageman factor (Factor XII} and plasmin are involved in 
blood clotting-fibrin system. 
One of the earliest events in an i.nflanunatory pro-
cess occurs in the microcirculation of ·the inflamed area. 
Transient arteriolar constriction in the inflamed area 
occurs first (6} to be followed in a few seconds by marked 
dilation (7). The latter is associated with hyperemia or 
increased blood. flo~1·· ( 8) ~ Spontaneous vasomotion becomes 
less evident in the progress of an inflammatory reaction 
and eventually disappears completely. Edema of the affected 
area is formed as a result of increased vascular permea-
bility and the loss of plasma proteins into the tissues (7}. 
The events associated with edema constitute the secondary 
phase of acute inflammation. During the tertiary phase of 
inflammation, the endothelial cells are damag-ed and become 
s1-vollen. 'l'he vessel lumens are narrowed and become more so 
by thd adherence of leukocytes, platelets and erythrocytes 
4 
Table I: Classification of the media·tors in inflammation (5). ------
Type ________ A_g~e __ n_t ______ __ 
1. Histamine, 
Serotonin 





Chemical Nature ____ Origil! ___ _ 
Stored amines Basophil, mast cell 
platelets 
Acid lipid Leukocyte 









6. Hageman factor, 
activated 
7. Complement 
























to the endothelial surface. Initially the vascular changes 
involve the venules but then capillaries are affected. 
When this occurs, blood stasis results due to a loss of 
water and plasma primarily from the venules (4) and the con-
current formation of tissue edema (7,8). The fundamental 
cause of this stasis is presumably due to certain altera-
tions of the vascular wall -- the blood-tissue barrier 
which is made up of an endot_h_eJ~LaL_lin.in_g_res±ing_on .net----------
basement membrane. Necrosis of the inflamed area begins 
as a result of anaerobic tissue metabolism. 
Histamine, a vasoactive amine, is released from mast 
cells and platelets (4,8). The mechanism of histamine re-
lease in the inflammatory process remains unclear but several 
postulates have been made. One states that the release 
occurs via the presence of proteolytic enzymes (9), and 
another states that the release is accomplished by two types 
of antigen-antibody reactions (10,11). The first type in-
valves a lytic reaction requiring complement and the second 
one is an anaphylactic reaction. Upon lysis of the poly-
morphonuclear (PMN)-leukocytes, lysosomes disrupt the mast 
cells, releasing histamine into the circulation (12). After 
the release, histamine causes a separation of endothelial 
cells {13} and can be found in the early exudate. 
Serotonin, of lesser importance than histamine, is 
released during the aggregation and breakdown of plate-
lets (6,14). This mediator has a possible role in the early 
6 
phase of increased vascular permeability (8). Serotonin 
is reputed to stimulate chemoreceptors of the large vessels 
causing vasodilation. 
•rhe kinin sys·tem has been well studied as an inter-
mediator of the inflammatory mechanism. The pathway leading 
to the formation of bradykinin is initiated by the activa-
t.ion of Hageman factor ,...,hich results in the conversion of '··· 
three plasma proenzymes to their active forms (14). A 
schematic representation of .the pathway is presented i.n 
Figure 1. Plasmin also has a crucial role in launching early 
inflammation with the formation of kinins. Since the active 
forms of clotting· factor XI, plasmin and kallikrein all have 
strong influence on the activation of Hageman factor, they 
are therefore regarded as positive feedback modifiers of 
the 'pathway (16). Kallikrein acts on pharmacologically 
inactive kininogen by splitting into the nonapeptide, 
bradykinin, which has been shown to be a potent vasodilator 
and px-cmctc:r of increased venular permeability. Once brady-
kinins have been formed, they have a very short half-life 
in circulation since they are inactivated by blood plasma, 
erythrocytes, gr~nulocytes and kinases (17). 
Recently, there has been experimental evidence that 
a balance between the concentrations of tissue cAMP and 
cGMP is important in conditioning the intensity and time 
course of the inflammatory reaction (18). The inflammatory 
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Figure 1: Schematic representation of the plasma kinin-forming !pathway (15) 
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intracellular concentration of c.ANP and a higher concentra-
tion of cGHff. In· other words, the chemical mediators- are 
all regulated by the cyclic nucleotide concentrations, 
i.e. the production of serotonin, histamine, the brady-
kinins and prostaglandins is inhibited by an increase of 
c.ANP concentration whereas an increase in cGMP concentra--
tion increases the chemical production of these substances 
and increases the potentiaL.£.or__in£.Lamma±..i.on .•. ~-------------
Prostaglandins were only recently discovered to 
play a strong role in inflanunation (19), and much work in 
this area has been undertaken since then. Prostaglandins 
differ from histamine or serotonin in that the permeability 
effects of prostaglandins are due to a ~-r~~ct. act.i.on on 
the microvasculature (20). Prostaglandins also differ 
in that they inhibit a sustained action on cutaneous ves-
sels, in particular (21), and they have the ability to 
counteract the vasoconstriction caused by norepinephrine 
and angiotensin (22). Several experimental models of 
inflammation have shmvn evidence that prostaglandins are 
the terminal mediators in acute cases, and involve the 
complemen·t systen1 (20}. After being synthesized in PMN 
leukocytes, prostaglandins (mostly of type E~ are released, 
and help perpetuate the inflammatory reaction by bringing 
forth additional leukocytes. Prostaglandin E
1 
has also 
been found to play a strong supportive role of increasing 
vascular permeability in inflammation (23). The maintenance 
9 
of prostaglandin generation and of inflammation may result 
via invasion of the target inflamed area by PMN leuko-
cytes (24)' Prostaglandin release is accomplished by 
phagocytosis, and this release in turn stimulates the influx 
of more phagocytes (25). Therefore, phagocytosis may con-
tinue as long as the injurious agent is present at the 
target sites. It has been suggested that the phospholipases 
freed from vso~s_Qm_e_g___libex_a±e_ara..chidon i C-cteitl-:f-J..~o.m-pbo Q=·--------
pholipids since phagocytosis leads to the release of lyso-
somal enzymes (26). Arachidonic acid is a precursor in 
the biosynthesis of prostaglandins. 
The complement system, consisting of at least 11 
distinct serum proteins, can be found in reticuloendothelial 
cells and liver. The final biosynthetic products of this 
system are not necessarily involved in inflammation, but 
the intermediate reaction products and complexes have im-
portant roles in the inflammatory process (27). Some of 
the agents can cause histamint~ release from mast cells as 
well as changes in vascular permeability and the enhance-
ment of phagocytosis. These agents are chemotaxis in 
nature. The property of chemotaxis is the vectorial motile 
response of phagocytes to inflammation (28). For example, 
a spli·t product of C3 (one of the distinguishable comple-
ments) becomes a chemotaxic factor for neutrophils upon 
addition of plasma into the serum of rabbit or human (29). 
The C3 fragment also has been known to trigger the reaction 
10 
where the increased vascular permeability in early phase of 
acute inflammatory response makes its sudden appearance (7) • 
. C5 cornplemen·t is similar to C3 in the respect that ·they both 
serve as a substrate for the release of a biologically 
act.ive phlogistic product, but differ frorn each other in 
physiochemical properties (30). The complement system along 
wtth t:he lysosomal enzymes are two of the intermediators 
enzymes can be found sequestered in PMNs, mncrophages and 
mast cells, and provide them with the necessary machinery 
£or making certain of the mediators expected in the acute 
in.eli:unrnato:ry response (31) . 'rhey digest a variety of intra-
cellular and ext:ra.cellular molecules, and can produce 
vascular injury (hemorrhagic necrosis). The lysosomal en-
zyrnes in:f;luence the inflammatory process by disrupting 
mast cells, increasing the permeability of vessels, further-
ing chemotaxis and by injuring normal tissue. 
While lysosomal enzymes contain stored int:r.acellu-
la.r proteins in PMN leukocytes, lymphokines contain newly 
synthesized intracellular proteins found in stimulated 
lymphoc:,rtes (5) • · Lymphokines are a g:coup of hypersensitive 
mediators which include a transfer factor, permeability 
facto;r f macrophage aggregating factor, chemotaxic.: factor, 
lymphotoxin a.nd others (32). Their role in. inflammation is 
rather unclear but they all contribute to the delayed hyper-
sensitivity reaction by converting normal macrophages into 
activated ones to engulf and kill any pathogens they may 
encounter as in the case of chronic inflammation. Recen·l.:ly, 
11 
it has been found that prostaglandins, especially of the 
E type, regulate the lyrnphokine secretion; in other words, 
the regulat:ion of PGE1 or PGE2 on lyrnphokine production 
depends on the existence of distinct subpopulations of 
lymphocytes (33). 
During the early phase of acute inflammation, the 




(both are known as mononuclear phagocytes) (27). These 
phagocytes ingest cellular debris, injured cells and other 
factors which influence the st:imulation of inflanmmti.on. 
These cells emerge from the bone marrow into the injured 
site and contain peroxidases and lysosomal enzymes (28). 
In phagocytosis, the lysosomal enzymes predominate. Mono-
nuclear phagocytes are important i.n inflammation as the 
body's resistance against infection as well as for tissue 
repair and healing (27) . In the late phase of an inflam-
matory reaction, these cells seem to be involved more 
heavily in the immunological process. 
The inflammatory process up to this point (where 
lysosomes and lymphokines play their action) is generally 
termed as the "exudative-degenerative" stage of inflamma-
tion (6}. The "walling off" process results when vascular 
stasis, accompanied by formation of loosely organized 
fibrin clots, occurs along with .the localization of the 
inflammed site and local tissue destruction (7). The final 
12 
stage of an inflammatory process appears as fibrous tissue 
growth is initiated and rapidly proliferated at the peri-
phery of the site of inflammation. This proliferation takes 
place when fibroblasts and small blood vessels penetrate 
the exudate. This process occurs via mitosis of connective 
tissues and endothelial cells. The "reparative or prolifera-
tive stage" follows after the inflammatory exudate becomes 
mass. 
Mechanisms· of Pain. The production of pain is a complex 
process and a perplexing one. There are several schools 
of thought in regard to pain mechanisms, of which one 
strongly predominates today. The reason for diversified 
views among scholars is that pain is a multidimensional 
experience. This experience not only involves the dis-
criminative ability to identify the onset, duration, in-
tensity and physical characteristics of the stimulus, but 
also involves the motivational, affective and cognitive 
functions leading to an aversive behavior {private experi-
.ence of unpleasantness) and the interpretation of the stimu-
lus in terms of presen·t and past experience (34,35). ~l'he 
reactions experienced by humans vary as influenced by age, 
sex and race. Pain is commonly produced by stimuli which, 
at weaker intensities, evoke other somatic sensations 
such as warmth or cold, or mechanical contact. 
It has been generally accepted that pain from the· 
~-
13 
cutaneous surface is dual in nature. There are two specific 
sets of peripheral nerve fibers which are differentially 
nociceptive in function (35,37). Nociception is a broad 
term defining a type of receptor which responds to damage 
of tissues whether the damage is physical or chemical. Ana-
tomically, a nociceptor consists of free nerve endings. 
For some scholars, a "nociceptive afferent" is a more approp-
riate term than "pain" fiber. General!}'_, the latter term 
is considered as a shorthand for the more cumbersome phrase. 
The short latency pricking,pain evoked by a noxious stimuli 
is followed by a second long-latency pain of burning and 
less bearable quality. Nerve fibers are classically divided 
into ·three groups: type A which consist of myelina·ted 
afferent and efferent somatic nerves; type B which consist 
of myelinated preganglionic sympathetic fibers; and type C 
which consist of unmyelinated somatic afferent and unmyeli-
nated sympathetic fibers. Types A and C are both involved 
in the transmission of pain. Type A fibers are further 
divided into alpha, be-t:~, gamma and delta, in the order of 
decreasing diameter. Delta and gamma fibers predominate 
over the other two in pain transmission (38). Therefore, 
~~lta-·type A and ~aroma-type A (to a lesser degree} fibers 
are the ones associated with short-latency pricking pain 
while certain type C fibers transmit the burning sensation. 
Evidence for the discrimination between type A and C fibers 




(39) and Lewis et al. (40). They reported that by appli-
cation of a local anesthetic agent, the cutaneous nerve 
was blocked. Only type A fibers were conducting as evidenced 
by the absence of aching pain and the presence of pricking 
pain. 
Specificity, pattern and gate-control theories are 
the three principal physiological concepts of pain mech-
anisms. The ga·te-control theory is probably the mostly 
widely accepted these days with several correlates. Speci-
ficity and pattern theories are the opposite of each other 
whereas the gate-control theory is the most complex process 
of all three. 
Specificity theory states that a group of certain 
pain receptors .i.n body tissue (cutaneous skin, for example) 
have a specific pathway to a pain center in the brain. 
This was proposed by several groups including von Frey 
around the turn of the century (41). Today, this theory 
implies that the free nerve endings are the receptors and 
the pain impulses-travel_:_ via~ d~lta ... type A and ty:f>e C fibers~"> 
in the periphery (42). From there, the impulses travel 
by the lateral spinothalamic tract of the spinal cord to 
a pain center in the thalamus. The strong point of this 
theory is physiological specialization, yet its major 
weakness is its psychological assumption. To say that a 
receptor is a pain receptor means that only pain and no 
other perception must be felt there; this is a psychological 
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assumption (43). Evidence has been brought forth that 
there are receptors and fibers of the· sk:i.n sensory syste'I\t-
which show a very specialized function, but it is argued 
that no evidence exists that there is a specific group of 
receptors and fibers involved with the pain modality (44). 
Pattern theory was first proposed by Goldscheider 
who stated that the stimulus intensity and central summation 
-
" 
were the most cri±i_ca.L_dat...e--r...mj_nan-ts-O-f-p<'!.-i-!1-(-4-5-)-.----I-i;-wa-s~------
proposed that a specific touch system, comprised of large 
cutaneous fibers, helps the smaller fibers converging on 
dorsal horn cells and sums their input, transmits the aug-
mented pattern to the brain to be perceived as pain. Sev-
eral refinements of this theory have emerged, and all are 
generally grouped under this pattern theory. Livingston 
proposed that intense, pathological stimulation sets up 
reverberating circuits in the spinal internuncial pools or 
evokes spinal cord activities as reflected by the dorsal 
root reflex which can be triggered by non-noxious inputs to 
generatE': abnormal volleys ( 46) • '.rhese volleys are inter-
preted centrally as pain. An extension of Livingston's work 
has brought out the fact that a specialized input-controlling 
system normally prevents summation from occurring, and that 
destruction of this system leads to pathological pain 
states (47,48,49). The slow system (those with type C 
fibers) dominates over the fast fiber system and produces 
the following results: slow pain (47), diffuse burning 
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pain (50) or hyperalgesia (48). 1wo authors, Weddell (51) 
and Sinclair (52), have proposed that the production of 
cutaneous qualities are brought forth by spatiotemporal 
patterns of nerve impulses. This differs from Livingston's -
~= 
·theory in that the separate modality-specific ·transmission 
routes are not applicable. Their theory proposed that all 
fiber endings (not those innervating hair cells) are alike. 
Thus, the attern for pain can be p_r_o_d_tLe_ed_,_hy~iJLt.E.ns_e_sJ:Jmu!.=-=--------
lation of nonspecific receptors. But this theory is lacking, 
as evidence has been shown £or high receptor-fiber speciali·-
zation (50). 
The specificity theory is inadequate .in ·that there 
is no evidence of any one-to-one relationship between physic-
logical specialization and psychological events (44). In 
other words, we have only a loose association of function 
(specified pain with fiber diame·ter and receptors). Like-
wise, pattern theory. is vague in giving an account of 
somesthesia. Considering the above and physiological evi-
dence on spinal mechanisms along with the evidence of central 
over afferent input, Melzack and Wall proposed a gate-
control theory (43). This states that stimulation o~ the 
skin evokes nerves that are transmitted to three spinal 
cord systems: (i) cells of substantia gelatinosa (SG) in 
the dorsal horn, (ii) the dorsal column fibers that project 
toward the brain, and (iii) the central transmission (T) 
cells in the dorsal horn. Figure 2 depicts the theory. 
~-
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Figure 2: Schematic diagram of the gate-control theory. (43) 
SG = substantia gelatinosa; T - central transmission cells 
+ = excitation; - = inhibition. 
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Melzack and Wall further stated: 
"We propose that (i) the substantia gelatinosa 
functions as a gate-control system thai.: modulates 
the afferent patterns before they influence the 
T cells; (ii) the afferent patterns in the dorsal 
column system act, in part at least, as a central 
control trigger which activates selective brain 
processes that influence the modulating proper-
ties of the gate-control system; and (iii) the 
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T cells activate neural mechanisms which comprise 
the action system responsible for response and · 
perception. Our theory proposes that pain phenomena 
are determined by interac·tions among ·these three 
.J!--.----------b-"'y ..... s-t-em.::; ••.. We-rrreJpo-s-ed-t-hat-thre-e-r-e-o:tures o t th~e~------­
afferent input are significant for pain: (i)the 
ongoing activity which precedes the stimuli:is, (ii) 
the stimulus-evoked activi·ty, and (iii) the rela-
tive balance of activity in large versus.small 
fibers." 
'I''nere was a 1<veal th of evidence to support the theory. 
Mendell and Wall suggest that SG acts as a gate-control 
system modulating the synaptic transmission of nerve impulses 
from peripheral fibers to central cells (53). The presynap-
tic terminals of afferent fibers are inferred as the site 
of action ·whereas SG is the actual control mechanism. Also, 
the volleys of nerve impulses in large fibers are initially 
very effective in activating T cells but their later effect 
is reduced by a negative feedback mechanism (54). Like-
wise, the volleys from small fibers activate a positive 
feedback mechanis~, exaggerating the effect of arriving im-
pulses. In other words, small diamter nerve fibers (type C 
and Q~_l t~-type A) activate brain structures serving aversive 
drives (sensational, motivational and "af;F.ective) whereas 
larger ;fibers (al)2_ha_-type A) provide spatial and temporal 
discriminating capacity (55). Melzack and Wall went on to 
propose that once the ;lntegrated (su;rnrnP.t;lon) ;!;:l:r;i.n9-level 
of T cells exceeds a certain point, the firing triggers 
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a sequence of responses such as the startle re;i;lex, vocali-
zation, etq. (43) • 'rhey also believed that since there is 
no "pain center" in the brain, the triggering of the T cell 
system marks the beginning sequence of activity which occurs 
when the body sustains damage. Three years ·later, Melzack 
and Casey went fur the bv mo_d_i_:E_:'t-in_g_the_then~'t"-Y-S-O_.t h a~t~p~ i ~.L-------
could be defined in terms o;l; three determinants -- sensory, 
motivational and central control which can interact with 
each other to bring on an effect or response (35). This 
means, if injury or any other noxious input fails to evoke 
aversive drive produced by stimulation of reticular and 
li_mbic system structures, the experience is not labelled as 
pain. 
While the gate-control theory has been widely ac-
claimed, there has been some appealing evidence indicating 
the invalidi·ty of this theory. )?or example, there is no 
direc!:_ evidence that large and small fibers excite the T 
cells, that large cutaneous afferents excite the SG cells, 
a,nd that SG cells inhibit presynaptically both large and 
small 9.ffe:r.ents (56) • No such evidence is apparent due to 
the limitations of experimental technique. Also, several 
clinical syndromes such as phantom limb,· ·tic doHloureax 
and trigeminal neuralgia do not fit into the pattern of 




can simply occur in the absence of peripheral input. This 
syndrome is not explained by Melzack and Wall's first 
postulate in which there has to ·be enough input to trigger 
the activity in the T cells. Tic doulourea~ does not fit 
into the second postulate in ·that there is no sensory loss; 
in other words, there is no marked loss of large peripheral 
nerve fibers so as to close the gate. 
'l'h-e-trrterrelal:ionships between pain and inflammation 
along with pain and vasodilation have been studied for 
years-- as early as the turn of this century (59). A regu-
latory site in the central nervous system for inflammation 
w-as first proposed in 1845 (60). Evidence for this role has 
been presented to show the attenuation or abolishment of 
inflanm1a·tion by spinal transection, sensory nerve block 
and acute or chronic denervation near the inflammatory site 
(61) • Whether the distal terminals of nociceptive afferent 
delta-type A and type C fibers can be excited directly by ·----
noxious stimuli is uncertain, there has been an accumula-
tion of evidence that injury to tissue cells releases 
chemica.l substances from them. These chemical substances 
may be potent activators of nociceptive fiber endings or 
chemo;r.eceptors (59). When the symptoms of inflammation 
appear, the local area of flare appears to exhibit more 
intense pain when the area is pin-pricked than before the 
onset of inflamnl'ltion. The pain threshold apparently has 
been lowered (59,62). This heightened sensibility is termed 
h-
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as primary hyperalgesia (47). Secondary hyperalgesia occurs 
when hypersensitivity to pin-prick develops in a wide region, 
outside the flare and when the pain threshold is not lowered. 
Those tv10 hyperalgesias diffe·r in casual mechanisms (59). 
Upon the injury of cutaneous skin, redness appears as a com-
ponent of the inflammatory response. This represents neuro-
genic vasodilation and may be mediated via the release of 
one or more vasodilator substances. It has also been 
inferred that the peripheral nervous system can further 
the disintegration of tissues (62). With the enhancement 
of local inflarrm1ation, the organism is protected at the 
cost of the integrity of a part. 
Experimental evidence has shown that vasodilation is 
an axon reflex with the impulses traveling centrally from 
·the region of injury (59) • These impulses are conducted 
antidromically over other branches of nociceptive afferents, 
invade their endings and elicit the vasomotor changes. Auto-
nomic efferents are not involved. The antidromic invasion 
of type C fiber terminals either release or cause the forma-
tion in the intercellular fluid of a substance having the 
-------------------- ---
properties of activatin~ the endings of nociceptive affer-
ents (63). One research group has indicab~d that while 
there was direct evidence of existence of neurogenic in-
flammation as elicited by antidromic stimulation, they could 
not support the strong role of axon reflex in producing 
inflammation (64,65). 'l'etrodotoxin, a potent local anesthetic 
22 
known to selectively block axonal conduction, did not pre-
vent the inflammatory process induced by neurogenically 
acting irritants. 'l,he workers, instead, proposed that a 
"mediator" was released from sensory receptors as they were 
activated by orthodromic sensory stimuli or by antidromic 
nerve i1npulses in neurogenic inflammation. These same 
receptors also subserve the chemogenic path. 
of pain (and in many cases, in the mechanism of inflamma-
tion), it has been demonstrated that upon cellular injury 
one or more proteolytic enzyme3 are released into the inter-
stitial fluid (66,67). These enzymes act on gamma globulins 
to produce a series of polypeptides acting as vasodilat.ors 
and as ~xcitants of nociceptive afferents. These polypep-
tides are also released v.rhen impulses pass antidromically 
in the terminal branches of certain peripheral nerves having 
l~ 
their cell bodies in a dorsal root (59). One of these 
polypeptides has been identified in one research group as 
neurokinin, a specific bradykinin (59,68}. Thus, in primary 
hyperalgesia, proteolytic enzymes are released from injured 
cells in the region of the local flare by action of anti-
dromic impulses in type C fibers. However, in secondary 
hyperalgesia, no peripheral mechanism is accounted for. It 
has been suggested that this may result from the heightened 
level of excitability in internuncial neuronal pools re-
ceiving afferent input from both the injured and the second-
ary hyperalgesia regions (69). 
23 
The late Dr. l\. K. Lim provided another "school" for 
pain mechanisms which refutes what has been discussed in the·· 
last few paragraphs. He produced strong evidences that pain 
receptors were not nociceptive but were chembceptive (70, 
71,72). Classical studies dealing with stimuli which evoke 
somesthetic sensations have come to the conclusion that there 
are three types of receptors namely: mechanoreceptors, 
pain and a,che, and reflec·ts the common association of any 
fonn of high intensity stimulus with pain. Previous investi-· 
. gations had overlooked that this type of receptor can be 
damaged and fail to give a second response. Lim stated 
that when n+ and K+ ions, some amines and the bradykinin 
peptides w·ere applied in physiological ccncent.:ra·tions, the 
11 nociceptors'' would give a pain response. These receptors 
a,re, in fact, somesthetic chemoreceptors which also respond 
to nociceptive stimulation of their axons or. receptor ter:mi-
nals. Pairi~ therefore, forms part of somesthetic image 
created by the contributions of three basic somesthetic 
modalities: the mechano- 1 thermo- and chemosensa·tions. 
When an injury strikes, all axons and receptors within the 
damaged area (either cutaneous or visceral) are stimulated 
as to evoke their specific sensation. They, in turn, con-
t:r-ibute to the somes the tic image of pain evoked. However, 
cent.ral factors of facilitation and inhibition at the time 




the image. Peripheral factors may also play a part in 
influencing pain (73,74). 
Within each of ·the three groups of somesthetic re-
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ceptors, there lie differences in specificity which can be 
morphological as well as physiological (71). Most of the 
receptors are not encapsulated or organized but are of the 
free--branching type as seen in thermoreceptors and chemo-
i 
~--
re ce tors . While sensa i.o.ns_....O_f_to..uch___a nd-pr.essu-.r.-.e~a-x-.e,___ _______ _ 
elicited by the mechanoreceptors and the t:herrnoreceptors are 
temperature sensitive, the chemoreceptors are excited by 
inju~y or any stimulus modality intense enough to constitute 
supramaximal stimulus to an axon. Lim strongly believed 
that the receptor for pain was a specific somesthetic chemo-
receptor and that bradykinin was the mediator in the stimu-
lation of both type C and delta-type A fibers (72). The 
bradykinin-sensitive receptors are generally distributed 
throughout the body. They evoke pain upon stimulation by 
the algesic peptides, and upon stimulation of its axons and 
receptor terminals by nociceptive and by non-nociceptive 
stimuli after ischemic and inflammatory sensitization. 
~rhis provides the most satisfactory reason for their accep-
tance as the sole receptor for the mediation of pain. Since 
bradykinin is readily destroyed by kininases in plasma and 
lymph glands, it may be suggested that its target organ 
cannot be too far mvay. Evidence has shown that since 
bradykinin evokes pain upon intrarterial injection throughout 
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the body, it may be assumed that the pain receptors are 
located close to the capillaries (75,76). Figure 3 illus-
trates Lim's proposed role of injury and inflammation in 
the genesis of pain. 
One research group has refuted Lim's theory of 
bradykinin as a mediator of pain (77). Their evidence 
demonstrated the fact that pain could easily be produced 
by intramuscu.Lar, subcutaneous or imradermal inJections of 
other substances such as hypertonic saline, potassium 
chloride solution and histamine. It was stated that another 
mechanism must be postulated for pain mediation which would 
involve chemical mediators other than the polypeptides of 
bradykinin. 
Recent research on the prostaglandins has brought 
fon.rard compelling evidence that the prostaglandins may play 
an active role in the production of hyperalgesia. Ferriera 
and Vane have made several interesting conclusions in this 
area (22). Lipoperoxide intermediates in the prostaglandin 
biosynthesis pathway along with high concentrations of 
prostaglandins E1 and E2 , may have pain producing properties~ 
They are dependent on the intensity of activation of the 
pros-taglandin-generating system by trauma. Acute type of 
pain may be caused by the generation of an intermediate 
vlhich exceeds its conversion to prostaglandins E1 and E2 in 
low concentrations. Such compounds have been demonstrated 
to sensitize the pain fibers to mechanical and chemical 
r INJUR~ , 1 ',,',,, 
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To stem axons and terminals of 
superficial paravascular 
chemoreceptors and other 
cutaneous receptors. 
1st line of warning 
l '',,, Immediate cutaneous pain 
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stimuli. Since the effects of the E prostaglandins are 
cumulative and long lasting, minute amounts of them at a 
site of injury could sensitize nerves. With such sensiti-
zation, other mediators such as bradykinin and histamine 
could cause pruritis or pain. 
~1ethods of Screening. In order to test a potential anti-
inflan~atory agent, a model of experimental inflammation 
has to be utilized. While ·the mechanism of inflammation 
remains poorly defined, many animal models have been devised, 
especially in thG past 20 years. Some models resemble 
acute inflammation while others have a similarity to chronic 
inflammat.ion. Since the five criteria of inflammation are 
erythema, edem~, pain, heat and a lo~s of fundtion, research 
goes on searching for a model which will allow the determina-
tion of all parameters at the same time. At present, there 
are no experimental models which will allow this, although 
certain techniques may determine two of these parameters 
concomitantly. It has been stated that not one of these 
animal models is exactly analogous to any one of the various 
~-
huma.n diseases of inflammation in terms of infection, chronic 
physical or chemical irritation, endocrine disturbance and 
immunological disorder (78). 
~1 excellent review has been published describing 
the various models of experimental arthritis (78). One of 
the earliest models cited was reported in literature in 
1850 and involved lesions of cartilage. Around the turn 
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of century, much experimental emphasis was placed on 
bacteriological studies. Various bacterial organisms were-
introduced into the body to bring on arthritis or inflamma-
tion. For the past 100 years, chemical agents also have 
been utilized to produce an arthritic-like condition in 
animals. While such methods are relatively simplistic and 
reproducible, the changes observed in animals often do not 
the 1940's and early 1950's, several groups tried to produce 
experimental arthritis by altering endocrine metabolism in 
the animal models. One version of these experiments is 
still common today whereby the actions of potential anti·· 
inflammatory agents are studied in adrenalectomized rats. 
Immunological methods for the experimental production of 
arthritis have been tried out by several groups. It has 
been suggested that disturbed immunological mechanisms in 
rheumatoid arthritis are apparent. Some factors, including 
the location of gamma globulin on synovial margin, have been 
confirmed. ~astly, experimental arthritis can be induced 
by physical means such as local injection of irritants, 
local cauterization, local trauma, reduction in blood 
supply, etc. Gardner believed that physically induced 
arthritis most closely resembles degenerative joint disease 
in the human, but there is little real evidence for this 
( 79) • 




in experimental medicine, immunology, biochemistry, genetics 
and ultrastructural forms in the past decade have been re-
markable {79). Several promising models have been advanced 
as counterparts of rheumatoid disease. Homologous disease 
can be demonstrated by the injection of relatively large 
numbers of mature immunologically competent cells into new-
born animals, irradiated animals, or adult animals rendered 
tolerant b repeat_e_d__in-:j-S-G-t-ie:as----erf--:hrrg-e nufilbers of compe-
tent lymphoidal cells. The classical chronic symptoms of 
arthritis can be produced in rats by injection of Freund's 
adjuvant, although acute symptoms may also be produced. 
The la.tter method is widely utilized toqay to test potential 
new an·ti-inflaroma.to:r.y agents. 'rhis method, fi:r·st developed 
by Pearson (BC) and later refined by Pearson and Wood (81), 
employs the technique of injection of killed ~ycobacterium 
~mtyEic~ suspended in mineral oil (also known as Freund's 
adjuvant) into a rat's hindpaw. There is a "latency" period 
of approximately 10 days before articular lesions first 
appeaL in the treated paws and tails. Such lesions subse-
quently involve the skin {nodules of ears and feet) and 
eyes (conjunctivitis and keratitis). However, during the 
latency period, edema appears (the peak effect is around the 
fourth day and can probably be attributed to the irritant 
effect of adjuvant (82). The edema is accompanied by ery-
thema, ulceration and purulent discharges. PMN-induced 
leukocytosis is the likely factor in the primary hindpaw 
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swelling (83). The second phase involves not only the 
continuation of the acute symptoms (i.e. exudation of plasma 
fluid and proteins into synovial region) but also the develop-
ment of proliferative connective tissue reactions and the 
initiation of non-articular lesions (84). Drugs known to 
have an immunosuppressive proper·ty, may be administered to 
rats starting the day before the injection of adjuvant and 
mediated inflammation (appearing 11-14 days after inocula~ 
tion} is not seen (85). Immunosupressive agents are inef-
fective if given to the rats two weeks after adjuvant injec-
tion. A true anti-inflammatory agent will reduce inflamma-
tion but will not prevent the proliferative reaction and the 
development of non-articular lesions. Screening measurements 
for this type of research include plethysmographic record-
ings of changes in hindpaw volume (86) and subjective inflam-
mogram scoring (87). 
The method of cotton pellet granuloma, first devel-
oped by Meier et al. (88) and modified by Winter and Porter 
(.89), is a popular method used to check the ability of an 
anti-inflw~atory agent to interfere with the proliferative 
component of the inflammatory process. Two cotton pellets, 
10.0±0.5 mg., are implanted in the dorsal-caudal region of 
rats, and test drugs ·are given orally daily for five days. 
On the sixth day, the rats are sacrificed and the cotton 
pellets are excised out along with thymus and adrenal glands. 
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These wet pellets are immediately weighed and reweighed 
18 hours after being dried. Effects upon body weight gain, 
adrenal weight and thymus weight are determined at the same 
time. 'I'he parameter used is the percent inhibition of dry 
weight of granuloma formation by the formula, 100 (X-Y)/X--
where X is the gain in mg. dry weight of control pellets 
and Y is the gain in mg. dry weight of pellets in treated 
rats. 
Prior to 1962, the most frequently used phlogistic 
agents for the induction of acute inflammation were brewer's 
yeast, formalin, dextran, and egg albumin. The parameter 
measured was either the change in foot volume or foot 
thickness afte.r. pedal injection. Hany of these animal 
models have been shown to be non-specific (i.~, other drugs 
~tli thout clinically useful anti-inflammatory activity would 
reduce edema formation and large (often toxic) doses of 
anti-inflammatory agents frequently were needed to reduce 
edema formation. In a search for a more specific phlogistic 
agent, Winter et al. tried carrageenin, a mucopolysaccharide 
derived from Irish sea moss, Chondrus crispus (90). This 
method, today, ·is considered to be one of the fas·test, most 
economical and most reliable models of acute inflammation. 
With this method, all clinically effective steroidal and 
nonsteroidal anti-inflammatory drugs (at relatively low 
dose levels) show a gradual degree of inhibi·tion related 
to dose. Winter has reported that of all the known exudative 
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models of inflammation, carrageenin-induced pedal edema 
is the least susceptible to non-sp~cific inhibition (91). 
Eleven years later, Vinegar et al. gave an excellent review 
of the possible pathway involved in carrageenin-induced 
inflarr@ation (92). He stated, however, that the edema forma-
tion is not the result of inflammatory cell mobilization but 
is rather a consequence of cellular activity. This activity 
is most likely to be phagocytosis occurring after the mobili-
zation of neutrophils. 
Research Rationale. Most of the methods described so far, 
and those still in use, deal with only one diagnostic mark 
of inflammation. This mark is usually edema formation. 
Relatively few methods have dealt with pain, certainly one 
of the most important clinical marks of inflammation. On 
the other hand, some anti-inflammatory agents have been 
tested for their analgesic activity alone. One of the earli-
est methods reported in literature for testing the analgesic 
activity of anti-inflammatory agents was the introduction 
of 1% silver nitrate solution into the ankle joint of one 
hind leg of a rat (93). Twenty hours later animals were 
fed the test compound orally. Testing for pain (by flexing 
the acutely inflamed joint) was done at hourly intervals 
for five hours. This animal model was, however, rather non-
specf:f.:Cc: In 1965, Winter and Flataker reported an inter-
esting model in which anti-inflammatory activity (in terms 
of edema formation) and analgesic activity (in terms of 
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reaction threshold to pressure) of an agent could be 
tested concurrently (94). This has proven to be are-
liable and economical method. 
It is noteworthy to see tha·t up to the present date, 
no publication has reported the electrophysiological find-
ings associated with the inflammatory process. In other 
words, what does one find in neurograms of nerves con-
threshold experiments of Wint.er and Flataker (94} have pre-
dictably given false negative results due mainly to 
psychological factors, i ~e. t.he animal becomes conditioned 
to t.he piston pressure device early in the experiment and 
withdraws the pa.w at t.he slightest application of pressure. 
Therefore, it is the purpose of this investigation 
to study the electrophysiological (neural) effects of 
various common phlogistic agents. Time-course neurograms 
studies of these inflammatory agents will be reported here. 
Since carrageenin is the most widely used phlogistic agent 
at present, this substance has also been used to conduct 
neurogram studies involving prototype anti-inflammatory 
agents. Such studies may help define the role that the 








MATERIALS AND METHODS 
I. Animals 
Adult male Sprague-Dawley rats, weighing between 
150-260 g., were employed as experimen·tal subjects. These 
animals were obtained from S1monsen Laboratories of Gilroy, 
California seven days before use, and upon arrival were 
housed in a special temperature-controlled room (70-72°F). 
Cormnercial ra·t chow (Purina) and tap ~vater were allowed 
ad libit.um. 
was 
Each rat used for the electrophysiological study 
1 anesthetized with ethyl carbamate approxima·tely 
1.5 g./kg. intraperitoneally (30%). Rats receiving anti-
inflamma·tory agents were anesthetized about 10 minutes 
after the oral administration of these drugs. The rat was 
thPn secured, ventral side up, to a specially constructed 
rat holder. 'l'he tibiotarsal nerve of the left hind paw 
was localized by careful dissection and checked for identity 
2 using a stimulatox·. . The correct nerve provoked pa\.v move-
rnents upon stimulation. In order that the electromyographs 
-----------------
1 Reagent grade. Fischer Scientific Co., No. U-26. 




might not be detected in the neurogram through volume con-
duction, the electrodes were- isolated fromsurrounding--
3 muscles by a piece of 12.5 x 25 mm. latex-rubber sheet. 
Heavy mineral oil, warmed to 37°C, was applied in drops to 
the nerve preparation to prevent dehydration. Rectal tem-
4 perature was monitored continuously by a telethermometer. 
5 The probe of the thermometer was inserted to a constan-t 
range (35.6-36.7°C) a 60-watt incandescent bulb was utilized 
to provide radiant warmth as needed. 
II. Experimental station 
An aluminum plate (46 x 48 x 2 em.) housed the rat 
prepaz·ation along with several instruments (Figure 4}. The 
preparation was enclosed in a Faraday shield, constructed of 
screen (112 x 86 x 71 em.) to reduce electrical interference 
and 60Hz fields. The rat holder was constructed from hard-
wood contoured to fit the body of a rat. Two areas at the 
lower end of the wooden holder were chiseled into 25 mm.-
deep grooves for placemen·t of the hind paws during neurogram 
recording. 'l'he rat holder was screwed to an aluminum plate 
(200 x 230 x 3 mm.) and placed on top of a steel box 
(20 x 23 x 11 em.}. The rat holder and the plate were not 
3obtained from surgical gloves. 
4.Model YSI 43. Nanufactured by Yellow Springs Co. 1 
Inc., Yellow Springs, Ohio. 
51-1odel YSI 402. Nanufactured by Yellow Springs Co. 1 
Yellow Springs, Ohio. 
J 
Figure 4: Electrophysiolo·gica1 system de·sign· for recording_ 
the neurogram of a rat tibiotarsal nerve. 
a. Neurogram recording electrodes and micromanipulator. 
b. Grass Model Pl5 preamplifier. 
c. Tetronix oscillscope for electrophysiological display. 
d. Heathkit module system containing cards for the binary 
information of the neurograms. 
e. Hewlett-Packard frequency rate counter system. 
f. Panel contains two variable resistors; one for adjustment 
of trigger signals of neural recordings and the other 
for adjustment of input amplitude. Also contains con-
necting points for the oscillscope, Heathkit system, 
and servo chart recorder. 
g. Paw pressure transducer. 
h. Power supply for the pressure transducer~ 
i. Servo chart recorder. 
j. :t--licrometer syringe of 2 ml.-capacity and its holder. 
k. Rat holder. 
1. Tele-thermometer. 
m. Lamp with a 60 watt bulb. 







secured to the box so that they easily could be positioned 
to allow optimum placement of the electrodes on the nerve. 
To~make the rat holder moisture proof, varnish was applied 
twice. Three elastic bands (1.25 em. wide) were used to 
hold the rat securely in the holder -- one for each hind paw 
and the third one across the chest. These bands were placed 
so as not to interfere with peripheral and deep circulation. 
was bent to an angle of 55° 5 em. from one end. ~vo record-
ing electrodes, made from 18-gauge silver wires (99.9% pure), 
were epoxied to the short end of the rod. Those electrodes 
were spaced 6.35 mm. apart. Hooks were made on the elec-
L d d t d . h E 1' R 6 f . 1 t' h' ·..:.ro es an co a e w1. t poxy 1. te -or 1.nsu a 1.0n. T 1.s 
insulation was removed partially on the inside surface of 
each elect.rode to allmv intima·t:e contac·t with the t.ibio-
tarsal nerve of the rat. The electrode rod . was placed on 
a micromanipulator. A shielded cable connected the elec-
trodes to a Grass Model Pl5 differential preamplifier. 7 
In this study, logic circuits were employed to ana-
lyze the tibiotarsal neurograms obtained using the left 
hind paw of an anesthe·tized rat (Figure 5}. The sensory 
nerve action potentials first were detected and amplified 
6EpoxyliteR electrode insulator (#6001-M) and baking 
varnish (#6001). Manufactured by Epoxylite Co., Anaheim, 
California. 




Figure 5: ~chematic diagram of obtaining the binary 
information from rat left hind paw tibiotarsal 
neurograms an~_for~plication of pressure 
stimulus to the same paw. 
a. Grass Pl5 differential preamplifier with band pass 
set from 300 Hz to 3KHz. 
b. Tetronix RM 561 oscilloscope with vertical amplifier, 
Jl-------------"o'I'e-"t-EGR-i-X-~:i":t>e----3A-3---a-nd-t-ime-ba-se-, -Te~t:-.roTri--x-typ-er-2-B6 7:-.-------
c. Operational amplifier with follower circuit. It has 
a variable resistor of lOOKohms. 
d. Opera·tional amplifier with follower circuit. 
e. NAND gate inverter. 
f. Monostable multivibrator. 
g. NAND gate inverter. 
h. Voltage divider network and diode. 
i. Integrator. 
j. Resistor of 50 ohms. 
k. Monsanto servo chart recorder. 
1. 750 MFD 150 VDC electrolytic capacitor. 
m. Relay driver for the integrator circuit. 
n. NAND gate inverter. 
o. Frequency rate counter. 
p. Internal crystal clock of the frequency rate counter. 
q. NAND gate inverter. 
r. Relay driver for the pressure solenoid. 
s. Solenoid for application of pressure to the measured 
rat left paw. 







by a Grass Pl5 preamplifier. The band pass of the ampli-
fier was set from 300Hz to 3KHz at lOx gain~- The neuro:--
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grams '"ere subsequently displayed on a Tetronix RM 561 
oscillsocope. 8 Modification of the RM 561 oscillsocope \liaS 
made so that the ultra linear Tetronix type 3A3 differen-
tial vertical amplifier9 could be used for further signal 
amplification and impedance matching to the logic network 
used to analyze the neurograms. A Malmstadt diqital s~st~~-1_0 ________ _ 
was used to accomplish the binary information derivation of 
the neurograms (Figure 6). The output of the .Hodel 3A3 
amplifier was displayed on CRT and at the same time was 
transmitted to the first stage of the analyzer via its opera-
tional amplifier11 structured as a follower with variable 
gain. The output of the follower \vas presented to a voltage 
comparator. circuit12 employed as a level detector with 
1 mv. resolution over a dynamic range of 100 ~v. Pulse 
height discrimination and electronic identification of the 
nerve action potentials were effected by the voltage com-
parator. A five-volt logic state was obtained for each dis-
13 criminated nerve impulse neurogram via a NAND gate and 
8Manufactured by Tetronix, Inc., Portland, Oregon. 
9Ibid. 
10Manufactured by Heath, Co., Benton Harbor, Michigan. 
11M A 1 Olhe EU 900NA. Manufactured by Heath, co. 
12 Model EU 800MB. Manufactured by Heath, Co. 
13Model EU 800SC. Manufactured by Heath, Co. 
a. Original neural recording of sensory perceptions of 
a rat tibiotarsal nerve. Action potentials were 
approximately 10 microvolts in amplitude. 
n------~---~----=-------=-----c-.----------c---~------------- -----------------
b. Amplified action•potentials via follower circuit. 
c. Voltage comparator output. 
d. Pulse shaping by the monostable multivibrator circuit 
to a signal. 
e. Buffered logic. 
f. Integration of 10-second neurogram activity. 
g. Translation of stage f. as it would appear on t-he final 
recording, i.e. due to the speed of recording the "steps" 
of stage f. a:t,e not visible - see s<imple recordings. 
h. Sample recordings. Each "spike" represented a 10-
second sample period and there was a five-second delay 
between each sample period (hold state) - see following 
page. 
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passed on to the monostable multiv~brator circu~t14 ~ot 
pulse shaping. Here the width of each pulse signal was-· 
either increased or decreased to 0.5 milliseconds by the 
gated RC time circuit (monostable multivibrator). A second 
NAND gate was util~zed to buffer monostable output to a 
voltage divider (of 10 Kohms maximum) and diode network. 
The voltage divider limited the pulse height to approxi-
to an operational arnplifier used as a precision integrator. 
Technically it is difficult to construct a long-term stable 
integrator operating in a summing mode for periods greater 
than 10 seconds. Therefore, a 750 MFD 150VDC computer-
grade mylar electrolytic condenser15 was employed in the 
feedback circuit to overcome such problems. The output of 
the precision integrator was terminated into a 50 ohm 
16 line feeding a Monsanto strip chart recorder. The paper 
speed of the recorder was 100 seconds per inch; a sample 
recording can be seen as Figure 6h. The frequency rate 
t 17 tl . d th t t f th coun er , concurren .y rece1 ve e ou pu o e mono-
stable multivibrator to total the action potentials over a 
ten-second sample period. At the same time, the internal 
14 Model EU 800LA. Manufactured by Heath, Co. 
15 Type DCM, No. 539-2561-01. Manufactured by Sangamo, 
Springfield, Ill. 
16Monsanto ~·1odel 530A. Manufactured in West Caldwell, 
New Jersey. 
17 Hevllet·t-Packard Time Counter, Model 5304A. Manu-
factured in Palo Alto, California. 
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18 crystal clock of the rate counter initiated the sample 
and hold period of the precision integrator via shunt 
19 relays. The delay or hold period between each 10-second 
sample period was of five-second duration; i.e. the relay 
shunt was closed, thus discharging the 750 MFD electrolytic 
capacitator. This was reflected on the strip chart record-
ing as the pen made its excursion to zero. The information 
~------ pX-ov-id-e-d-0-n-t-he-s-tr-i-p-G-h-a-:I;t--~eeo~de-r----t-he-n -i-nEl-i c-a-teG--t-he- -teta-l~--
activity of the tibiotarsal neurogram over each ten-second 
period and also provided a·means to determine which part of 
the neurogram recording period registered maximum activity. 
A converted solenoid was used to deliver a constant-
pressure stimulus to the sole of the hind paw of the rat. 
The initiation of pressure application originated from the 
clock pulse of the frequency counter. A NAND gate, in con-
junction with a relay driver19 , switched the constant power 
20 supply of 7 volts and 0.1 amperes to the solenoid. There 
was a 5 mrn. travel with a force of 5 grams when the sole~ 
noid was energized. A 20 mm. screw with a 6.35 rnrn.-diameter 
flat top was soldered on the solenoid leaf to provide paw 
contact. The start of the pressure occurred as a result of 
18Hewlett-Packard Measuring System, Model 5300A. 
19Model EU BOOJD. lvlanufactured by Heath, Co. 
20Heathkit Regulated Power Supply, Model IP-28, 
Manufactured by Heath, Co. 
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the clock pulse; ~.e. a constant pressure was insured 
during each sample period owing to the design of the power 
supply which maintained constant current to ·the solenoid. 
III. Electrophysiological studies of variot.1s· phlog~stic 
aaents .::.:2,., ___ _ 
Four groups of 15 rats each were employed in this 
f . t h Al . 1 1 1 ' 21 1 th · J.rs· p ase. ong w1 t-  norma sa 1ne as centro , - ree 
, 1 • +- • +- ,f.. • , • .::1 • 2 2 , . 2 3 ----
ft------Pfl-.....-~-~*S-w-.L-G-a-<;Je-n-t,:;s-were-U-c-1~..a..-J,:-Z-eu- ;---ca-rr ageerr~ll1- --,-oe~ -cran-------------
24 and brewer's yeast. These materials were either suspended 
or dissolved in normal saline (1% for both dextran and 
carrageenin and 5% for brewer's yeast). The subplantar 
injections were as follows: 0.05 ml. for saline, carra-
geenin and dextran, and 0.10 ml. for brewer's yeast. These 
injections were made into the left hind paw using a microm-
eter syringe25 connected to a l-inch 27-gauge hypodermic 
needle by 30 em. of polyethylene tubing. The syringe was 
securely a·ttached to a holder on the aluminum board support-
ing the rat holder in order to prevent movement error by 
mechanical means during injections (Figure 4). A pedal 
21sterile 0.9% NaCl Injection, U.S.P. Invenex Co., 
Chagrin Falls, Ohio, No. 19103. 
22 . 
SeaKem Type I. Seaplant Chern. Corp., New Bedford, 
Massachusetts, No. 312503. 
23 s· o. 1 t' .. 1X-  so u 1on, ICN Pharmaceutical, Inc., Cleve-
land, Ohio, No. 101599. 
24compressed type, Fleischman's, New York, New York. 
25 •rwo-ml. capacity. Manufactured by Roger Gilmont 
Instruments, Inc., Great Neck, New York. 
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injection was not made until at least 30 minutes had elapsed 
after placement of the electrode. This waiting period 
allowed the surgical trauma to subside neurologically. 
Neurogram recordings were taken at the following 
times: +5, 10, 15, 30, 45, 60, 90, 120, 150 and 180 minutes 
after the injection of an inflammatory agent. An average of 
the four lowest neurograms (measured in millimeters) around 
---a,-p-r_e_s_c_r-t-b-e--a--ctme was taken as -t:he- expe_r_.i:rnen-fal- sFatistTc~.-=-----
Differences were determined as plus or minus values between 
the stated ·time and the control time periods. Averages, 
standard deviations and standard errors of mean were calcu-
lated using the methods of Bliss and Calhoun (95). Two 
comparisons were performed using the student t-test. One 
was between the control time values and the specified time 
period values within each treatment group while the second 
test was between the three inflammatory agents and the saline 
group within ·the same stated time period. 
IV. screening of drugs· using the electrophysiological 
te'cl1hi9;\.:.e -
Carrageenin was used as the common phlogistic agent 
for these anti-inflammatory screening studies. Five groups 
of 15 male rats each were employed -- each group receiving 
a different prototype anti-inflammatory agent: acetyl-
salicylic acid26 (300 mg./kg.), phenylbutazone27 (100 mg./kg.), 
-----------
26 U.S.P. Powder. Ruger Chemical Co., Inc., Irvington, 
New Jersey, No. 722233. 
27ButazolidinR, Ciba-Geigy Corp., Summit, New Jersey, 
No. SN20911. 
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hydrocortisone alcoho1 28 (20 mg./kg.), indomethacin29 
. 30 
(10 mg./kg.) and chlorpromazine hydrochloride (100 mg./k<J'• }. 
A control group received 0.25% agar suspension31 (10 ml./ 
kg.). The drugs were triturated or suspended in 0.25% agar 
solution, and concentrations were prepared so as to give 
the rats a constant dosage volume of 10 ml./kg. One hour 
before a rat was to be injected with carrageenin subplantarly 
=---------ci-n--e-e-~ne-1-e-f-~hi-nd--paw-1--the--anima-1-received a---randomly --
selected anti-inflammatory agent orally using a 5 ml. glass 
syringe and an 18-gauge oral feeding needle. The neurogram 
recordings and the methods of calculation were similar to 
those described in the preceding section. 
V. Pl~thy_smo~aph~<;? studies· of saline-induced pedal edema 
A group of 15 male rats were employed for plethysmo-
graphic studies of saline-induced pedal edema. The mercury 
displacement method of Van Arman ·et al. (96) was the model 
for this study. The apparatus used for recording paw volume 
was a Beckman Dynograph Type Rs 32 with .a Statham P23 BB 
28Nutritional Biochemical Corp., Cleveland, Ohio, 
No. 2912. 
29Merck, Sharp and Dohme Research Lab, Rahway, New 
Jersey, Lot No. 590226-00Al04. 
30
c 'th Kl' .. .-,ml . , 1ne and French Labs, Philadelphia, Penn-
sylvania, SKF#2601-A. 
31 Bacto-Agar powder, Difco Laboratories, Detroit, 
Michigan, No. 0140-1. 
32 Manufactured by Beckman Instruments, Inc., Schiller 
Park, Illinois. 
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pressure transducer. 33 The methodology of measuring paw 
volumes was similar to that described by DeCato et al. (97}. 
Anesthetization of each rat with sodium pentobarbital 34 
(30 mg./kg. intraperitoneally) took place just before 0.05 ml. 
of 0.9% saline21 was injected subplantarly into the left 
hind paw at 0 hour. The value of the injected paw was 
determined plethysmographically at each of the followin·g 
___ time_r>eriogs: -5 (con t_r_o_l_) ,_±5,_3_0_, __ 60_, 9_0_,_120_,_150_, __ 
180, 210, 240, 270 and 300 minutes post-injection. Three 
inu.-uersions at each time period were used to determine the 
average pa.w volume. The student· t-test was performed between 
the average control value and average readings at subsequent 
times. 
33 Manufactured by Statham Laboratories, Inc., Hato 
Ray, Puerto Rico. 
34 Nembutal SodiumR Powder, Abbott Laboratories, 
Chicago, Illinois, No. 3117, Lot No. 816-1739. 
RESULTS 
Figure 7 depicts sample neurogramsof a tibiotarsal 
nerve of rat left hind paw during the three-hour course of 
carrageenin--induced inflanuuation. Upon application of the 
constant-pressure stimulus, the intensity of the neurogram 
was initially increased to approximately 15 to 20 microvolts 
in almost all of the cases. Morever, as time progressed, 
more tibiotarsal action potentials were detected as evidenced 
by the lower section of each record. 
The neural activitiesof the tibiotarsal neurograms 
are compared among ·three phlogistic agents and the saline 
control in Tables II and III. In three-hour recordings, 
no significant differences were observed in the neurograms 
of rats receiving saline control only. Figure 8 depicts 
carrageenin's triple peaks which occurred +30, 60, and 150 
minutes after inflammatory injection. From +30 minutes after 
the in·troduction of carrageenin pedally to the termination 
of the experiment at +180 minutes, the results showed vary-
ing significant differences from both -5 minutes (control) 
readings and from the saline controls within the same time 
slots (Tables II and III). 
Brewer's yeast, as a phlogistic agent, showed a pro-
nounced monophasic peak 120 minutes after the subplantar 
51 
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Figure 7. Sample neurograms of tibiotarsal nerve of rat left hind ·i)aw following 
carrageenin-induced inflammation. , 
The upper section of each record depicts a neurogram whii.e the lower 
section depicts the voltage comparator outputs. i 
a. -5 minutes (control). b. +30 minutes after carrageenin injection. 





Table II: Mean values of total neural ac-tivity (mm. + 1 
SEM) of tibiotarsal _!lerve of r_at left hind Eaw. 
































































+ 1.74 + 1.42 
44,. 87 40.57 
±. 3. 91 ±. 3. 53 
4 8 . 7 8 41. -37 
±. 4.09a ±. 3.98 
46.73a 49.63a 
.±. 3.60- + 4.79-
48.77 52.83b 
± 5.09 + 5.13-
49.50b 50.32 
.±. 4.30- + 5.34~ 
55.03 58.57 
.±. 7.11~ ±. 8.26~ 
66.83c 67.37d 
±. 9.81- + 6.98-
77.55.. 52.68 




±.11.76~ ± 6.05~ 
Significantly different from -5 value within the same 
phlogistic agent group: ~P < 0.05; !?.p < 0.02; ~E.< 0.01; 
d 
--P < 0. 001. 
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Table III: Mean change in total neural activity (mm. ~ 1 
SE!1) of tibiotarsal nerve of rat left hind p~ 




































































































+ 7. 47-. 
Significantly different from the saline group value within 
the same time slot: ~P < 0.05; ~P < 0.02; £p < 0.01; 
dp < 0.001. 
Comparison of ·the tibiotarsal neural activities 
ofsa-line-treated {cont.-rol) and carrageenin-
treated groups • 
• Saline 
A Carrageenin 
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injection (Fi.gure 9). The graphical evidence is supported 
by the very significant difference in activity relative to 
saline control at this same time (Table III}. Increase in 
total neurological activity was apparent and significantly 
different from the -5 minute readings and saline control 
within their respective time slots almost from the start 
(+10 minutes) up through the last recorded neural activity 
------ -a-t-+-1-8-0-m±-n-u-t-e-s---.------ --- ---------- -------
Monophasic neural activity was also observed for the 
rats receiving dextran as the phlogistic agent (Figure 10). 
The peak occurred 90 minutes after the injection and was 
very highly significantly different from both control (-5 
minute) readings and the saline group at +90 minutes 
(Tables II and III). Like the rats receiving brewer's 
yeast, the increase in total neural activity in this group 
was evident from almost the time the agent was introduced 
pedally to the end of the experiment at +180 minutes. 
In comparing one phlogistic agent with the other, 
there were no apparent significant differences among the 
three groups. However, in the terms of the average mean 
values of total neural activity, carrageenin appeared to 
·be the most potent inflammatory agent neurologically (Table 
II). There were no significant differences among the four 
groups at -5 minute (control readings). 
II. Screening of a·nti-i~flammatory ·age·nts. 
A sample neurogram of tibiotarsal nerve of rat left 
--------------
Figure _ _2_: Comparison of the tibiotarsal neural activities 
o{ sa~ine-treated (control) and brewer's yeast 
groups. 
0 Saline 
A Brewer's yeast 
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hind paw in a phenylbutazone-treated (-1 hour) rat can be 
seen in Figure 11. The absence of initial response to the 
pressure stimulus is to be noted as compared to those neuro-
grams in Figure 7. Phenylbutazone suppressed the neurogram 
activity, most notably and significantly, at +60 and 90 
minutes after the introduction of carrageenin (Tables IV and 
V; Figure 12). The depression was significan·tly different 
(from +30 to +120 minutes after the subplantar injection). 
In comparing with the agar vehicle control group in the 
terms of time sequence, there were significant differences 
from +30 to +180 minutes after the carrageenin injection 
(Table V). 
The original values of the control (agar vehicle) 
group were altered in order not to differ significantly 
from the five anti-inflammatory gro.ups at -5 minutes (Ta-
ble IV) . Since one was able to adjust the number of tibio-
tarsal action potentials detected per ten-second sample 
recording at control time (-5 minutes), via the voltage 
comparator discriminator circuit, it appeared logical to 
add the arbitrary number of 11.57 to each time period 
reading of each animal in the control group. The value of 
11.57 was obtained from the difference between the average 
original control (-5 minute) reading of nontreated (agar 
vehicle) group and the mean of the averages of the control 
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Figure 11: Sample neurograms of tibiotarsal nerve of rat left hin;d paw following 
pretreatment '>vith phenylbutazone (-1 hour) and carrage:enin-induced 
inflaiT~ation. I 
The upper section of each record depicts a neurogram while the lower 
section depicts the voltage comparator outputs. I 
9. 
a. -5 min. (control). b. +30 min. after carrageeni~ injection. c. +60 min. 
d.. +90 min. e. +120 mi"n. f. +150 min. 9:.· +180 mini. 
I 




Table IV: Hean neurological effects of drug treatments (rn.1n. + 1 SEM) ~)f tibiotarsal nerve 






-5 +5 +10 +15 +30 +45 +60 I +90 +120 +150 min. 
48.40 54.20 84.00 53.97 64.40b 63.65b 76.09dl 69.64b 81.62c 92.47 87.10b 
+2.17 +3.91 +4.57 +4.86 +6.94- +7.11- +7.83-1+8.57 +11.76~16.16~17.59-
Acetylsalicylic Acid 49.60 53.68 49.97 46.02 44.83 37.06c 36.84b[ 36.67 47.68 44.77 34.27b 









48.58 50.70 43.77 47.52 37.27d 35.80c 31.25e[30.83e 34.35d 37.18 39.43 
±2.13 ±5.21 ±5.02 ±4.74 ±2.64- ±4.43- ±3.51- ±3.64- ±4.03- ±5.89 ±6.36 
46.75 47.75 46.38 45.48 37.92 37.66 37.08 48.10 53.78 58.05 60.51 
±2.05 ±5.10 ±6.39 ±5.08 ±5.85 ±6.50 ±4.50 ±7.64 ±9.51 ±11.68 ±13.00 
45.67 46.30 42.45 38.85 38.35 32.93b 30.60di31.38b 33.85 34.62 44.37 
±2.33 ±3.24 ±4.96 ±5.00 ±6.41 ±4.97- ±4.52-:±6.07- ±6.73 ±7.30 ±9.84 
51.35 58.58 52.53 48.27 
±3.70 ±6.00 ±6.34 ±5.92 
39.48 
±5.01 
37.43b 32.80d 29.22d 28.37d 31.57b 32.93b 
± 4 • 57 - ± 4 • 9 7- ± 5 . 13- ± 5 . 41- ± 7 • 41-- ± 7 . 4 6-
~The value of 11. 57 mm. was added to each reading in this group; see t<i~xt for details. Significantly 
different from the -5 value within the same anti-inflammatory group: lbP < 0.05; cp < 0.02; 
d e -P < 0.01; -P < 0.001. 
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Table V: Mean change in total neural activity (:m1n. ± 1 SEN) of drug ~reatments from -5 minute 
readings of tibiotarsal nerve of rat left hind paw following !carrageenin-induced 
pedal inflammation. . I 
Drug 
(mg. /kg.) +5 +10 +15 
Agar Vehicle +5.82 +2.45 +5.58 
{-----) ±2.73 ±3.71 ±3.50 
Hydrocortisone +1. 00 -0.37 -1.27 
( 20) ±4.98 ±6.20 ±4.86 
Chlorpromazine +7.23 +1.18 -1.02 
(10 0) ±4.61 ±5.83 ±5.22 
Acetylsalicylic Acid +4.08 +0.37 -3.58 
( 300) ±4.57 ±3.94 ±3.74 
Phenylbutazone +3.88 -4.82 +1. 80 
(100) ±5.20 ±5.45 ±4.85 
Indomethacin +0.63 -3.22 -6.75 














+45 +60 +120 +150 min. 
-------, 
+15.27 +27.70 +1121.25 +33.23 +44.08 +38.72 
±6.65 ±6.97 ±7.48 ±11.02 ±15.25 ±16.60 
I 
9 . 12b -1 0 . 3 3d !+ 2 • 7 0 + 7 . 0 3 +11. 3 0 + 13 • 9 7 
±6.87- ±4.84- ~8.19 ±10.02 ±12.21 ±13.37 
I 
i 
-13.90 -18.55 - 122.13 -22.78 £19.7(b -18.92 
±5. 32~ ±5. 06~ 1±5. 7l~.d.±4. 9J!!..I.. ±6. 7F-!-~ ±6. 76c ,e 
i 
I 
12.63 -12.77d -12.93 -2.6Q_ h -5.92 -15.53 
±4.30~ ±4.88- :±6.29~ ±8.2~±9.29c ±6.32~ 
I 
-11.82d -12.80 -17.33d -ll7.75d -14.23d -11.40 






12.73 -15.13d -l4.28d -11.82 -11.05 c i c c ±4.62- ±4.51- ~6.08- ±6.75- ±6.93-
-1.30 
±9.15~ 
Significantly different from the corresponding "agar vehicle" value wi·thin the same time slot: 
a b c d i -P < 0.05; -P < 0.02; -P < 0.01; -P < 0.001. · 
I 
Significantly different from the corresponding hydrocortisone value within the same time slot: 
~p < 0.05; ip < 0.02; ~p < 0.01. 
i 
Significantly different from the corresponding chlorpromazine value within the same time slot: 
h -P < 0.05. 
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~omparisQ~_of the tibiotarsal neural activities 
of agar vehicle (control) and phenylbutazone pre-
treat~d groups after carrageenin-induced pedal 
Inflammation. -
«~) Agar vehicle 
~ Phenylbutazone pretreated 
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As compared to the control time readings, the de-
crease in tibiotarsal activity was significant for indo--
methacin-treated animals for three time recorded periods: 
+45, 60 and 90 minutes after carrageenin injection (Ta-
ble IV). These three nadirs are illustrated on Figure 13. 
Yet, from +30 minutes to the termination of the experiment, 
this treated group showed significant differences from the 
ble V). 
Relative to corresponding agar vehicle group values 
in respective time periods, the rats pretreated with acetyl-
salicylic acid demonstrated significant differences in neural 
activity from 30 minutes after the introduction of carra-
geenin pedally to the termination of the experiment at +180 
minutes (Figure 14 and Table V). When compared to the con-
trol time values of this treated group (Table IV), the results 
are rather paradoxical. Only readings taken at +45, 60 and 
180 minutes after the pedal injection demonstrated the sig-
nificance between these times and the control time value; 
there~ore, this drug exhibited biphasic action neurologically. 
Hydrocortisone, known not to possess any analgesic 
activity, failed to produce significant decreases in tibio-
tarsal neurograms when compared to the -5 minute readings 
of those rats pretreated with this drug (Table IV). Figure 15 
indicates that after 60 minutes of induced inflammation, the 
curve rose to parallel the agar vehicle group curve. However, 
Fig:_ure 13: Comparison of the tibiotarsal neural activities 
of agar vehicle (contr-ol) and indomethacin-
pretreated groups after ___ cc.rrageenin-induced-
pedal fnfla1mnation. -
e Agar vehicle 
A Indomethacin pretreated 
Brackets indicate one SEM 
,~ 
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Figure 14: Comparison of the tibiotarsal neural activities 
of agar vehicle (control) and acetylsalicylic acid-· 
pretreated groups after carrageenin-induced inflam-
mation. 
o Agar vehicle 
A Acetylsalicylic acid pretreated 
Brackets indicate one SEM 
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Figure 15: Comparison of the tibiotarsal neural activities 
of agar vehicle (control) and hvdrocortisone-
pre!;_reated groups after carrageenin--induced- pedal 
inflarrunation. 
• Agar vehicle 
A Hydrocortisone pretreated 
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for 30 minutes (from +30 to 60 minutes) the differences 
between the two groups were significant. 
A pseudo-anti-inflammatory agent, chlorpromazine, 
was employed to compare with true anti-inflammatory agents 
for its possible effects on the peripheral nervous system. 
Dramatic increases in tibiotarsal neurograms were evident 
and were significantly different from the agar vehicle group 
at their respective times from +30 minutes after subplantar 
injection of carrageenin to the termination of the experi-
ment (Figure 16 and Table V). Interestingly, results in 
Table IV indicated that the decreases from the control time 
values were apparent from +45 minutes and on. 
It is not surprising to see that the differences 
between the hydrocortisone-treated group and chlorpromazine-
treated group were significantly different between +90 and 
180 minutes after the administration of the carrageenin 
pedal injection (Table V). At +120 minutes, there was a 
significant difference between the chlorpromazine- and 
acetylsalicylic acid-treated groups while at +90 minutes 
a significant difference was observed between those re-
ceiving hydrocortisone pretreatment and those receiving 
·phenylbutazone premedication. 
III. Plethysmographic studies of sa~.?:.ne-induced pedal edema. 
Table VI outlines the effects seen following the 
subplantar injection of 0.9% saline in the left hind paws 
Fio.ure 16: Comparison of the tibiotarsal neural activities 
of agar v:ehi.cle (control) -.imd chlO~oiT;azfn-e- ---
pretreated-groups-after carrageenin-:Lnduced--
inflam:raa tion. · 
e Agar vehicle 
A Chlorpromazine pretreated 
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Table VI: r-1ean volume of injected right hind paw (+ 1 SEH) fol,lowing pedal injection 
of normal saline. ' 
-5 +5 +30 +60 +90 +120 +150 +180 ', +210 
0.80 0.97 0.84 0.91 0.91 0.90 0.87 0.89 ! 0.90 
+0.04 +0. 0·3a +0.04 +0.06 +0.04 +0.04 +0.05 +0.04 I +0. 3 - -
aSignificantly different from the -5 minute value; p < 0.001. 
' 
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of 15 rats. Except for the +5 minute reading, there were 
no significant differences from the control (-5 minute) 




Studies of neurogram recordings in animals during 
the course of an inflammatory process have not been previ-
ously reported in the literature. The mechanisms of inflam-
mation and anti-inflammation, to this present dai:;e, rert1ain _____ _ 
poorly delineated despite the great advances in biochemical, 
immunological, endocrine and neurological technologies in 
the past 20 years. Since pain is the most distressing of 
the five cardinal signs of inflammation, this study is 
directed towards that sign. 
Obtaining neurograms in this present study was not 
without inherent problems. Transient or periodic electrical 
interference, especially the periodic 60 Hz electrical radi-
ation, had to be eliminated. Therefore, each article in 
the laboratory operated by AC line was carefully shielded 
and grounded to common point" To eliminate the interference 
problem further, a Faraday shield enclosed the whole labora-
tory work area. 
To devise "perfect" electrodes was another major 
problem. Electrodes had to be designed so that they con-
tacted only the involved 'nerve, so that the two electrodes 
could be maintained a constant distance apart, so that there 




by the operator, so that the electrodes could be used re-
peatedly in subsequent experiments, so that the electrodes 
were not toxic to nerves,· etc. The ~inal design incorporated 
99.9% pure s"iJver electrodes epoxy-coated except for the 
areas in direct contact with the tibiotarsal nerve. Possible 
accidental movement of the preparation during recording was 
eliminated by the following specifications: 
·c;!) the electrodes were made thick enough to be 
rigid; 
·e:ii) the animal was secured in a specially con-
structed, form-fitting holder; 
CitiJ. movement of the rat's paw which might dis-
place the electrodes during the injection of 
a phlogistic (or control) agent was elimi-
nated with the construction of a holder 
for the micrometer syringe and the intro-
duction of the needle into the paw before 
the start of neurogram recordings; and 
(iv) elimination of possible contact of electrodes 
with the surrounding muscles by the use of 
an insulating sheet of latex rubber. 
Classical studies recording the action potentials 
of nerves have indicated that delta-type A (and gamma-type A 
to a lesser degree) fibers exhibit higher voltage and are 
shorter in duration than type C fibers upon pressure stimu-
lation. This was confirmed in Figure 7A which represents 
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a control reading before the introduction of carrageenin 
into the hind paw. As the duration of the experimental 
inflammation (in the presence of carrageenin in the paw) 
is prolo!lged-1 dull aching pain becomes evident as in Fig-
ures 7b to 7g. 35 This is comparable to the studies of 
Winter and Flataker where the reaction threshold to a piston 
pressure stimulus was studied (94). However, the reaction 
threshold experiments failed to indicate the type of pain 
--- ---- -(pr-ic:King or aching) felt in the animals. Since the present 
investigator was able to monitor neural activity via oscillo-
scope it was possible to discriminate between the two types 
of "pain" in the present study; hmvever, the recordings on 
the strip chart recorder (the focus of this study) do not 
allow this discrimination. 
For some time, it has been well established by many 
research groups that the inflmmnatory process is activated 
by the presence of various chemical substances. Such chemi-
cal mediators are histamine (13), bradykinin (14), serotonin 
(8) and the E types of prostaglandins (20) -- all of which 
can be found in varying concentrations in inflammatory exu-
date. Likewise, these chemical mediators (bradykinin and 
the prostaglandins, in particular) have been confirmed to 
35For the rest of this discussion, the term, hyper-
algesia, will corr~spond to "total pain," ~.e. "pain" exper-
ienced as a result of the pressure stimulus as well as that 
associated with neurogenic inflammation. As the time period 
of' induced inflammation progresses, dull aching pain becomes 
more apparent thus potentiating the neurogenic effects seen 
-upon the pressure stimulus application. 
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play a role in the production of pain (22,59,72). From 
these observations, it appears that the nervous system has 
a strong participating role in the inflammatory reaction. 
Chapman and Goodell have discussed evidence (i) that the 
degree of inflammation can be either increased or decreased 
Via the action of the sympathetic nervous system and (ii} 
that the response of acute inflammation includes participa-
tion of local afferent nerves (98}. In their review, they 
further state that antidromic activity in afferent nerve 
results in the peripheral release of a vasodilator substance 
(a chemical mediator) . 
"A number of events associated with inflammation 
can be interpreted as indicating that antidromic 
impulses in afferent nerves result in the peripheral 
release of humoral agents that damage tissue or 
heighten tissue vulnerability, and influence in-
vasion, survival, and growth rate of microorganisms." 
The authors conclude that a chemical mediator must be re-
sponsible for neurogenic vasodilation and for the induction 
of burning pain -- a neurokinin. A recent paper has reported 
the effects of bradykinin and prostaglandin E1 on rat 
cutaneous afferent nerve activity (99). This paper con-
eluded that in the presence of a low concentration of prosta--
glandin E1 , bradykinin can manifest its action, and that 
both of these mediators potentiate their effects on afferent 
nerve terminals. The potentiating effect of prostaglandin E1 
is obviously dose-related since one research group observed 
in the dog knee joint that bradykinin became more effective 
in inducing pain as the prostaglandin level increased in the 
joint cavity (100). Bradykinin alone does not evoke dis-
charges from receptors (99,101). 
In terms of nerve types, prostaglandin E1 appears 
to affect mainly type A fibers. The larger spikes of type A 
fibers appear to originate from mechanoreceptors which have 
been activated by increased interstitial fluid pressure. 
This pressure results from fluid leakage into the circula·· 
tion during the inflammatory process (99). In an early re-
---- ~~- port-,--ehald-an-d -I:;add explained- that the early phase Of loca.r-- -
inflammatory edema (resulting from electrical stimulation of 
type C fibers) is most likely to be produced by amines re-
leased from mast cells (102). Histamine has been found to 
be independent of a neural mechanism but neural factors are 
known to contribute to its action (65). Although these 
authors were discussing the effects of neurogenic inflamma-
tion in human skin, they concluded that neurogenic inflam-
matory agents release a neurohumoral substance from sensory 
receptors which is responsible for enhancing the permeability 
of blood vessels, and that the axon reflex is not necessary 
for the induction of inflammation. However, an axon reflex 
is needed to produce flare (redness) -- the sensory nerve 
endings at both terminals of axon reflex arc release a perme-
ability-enhancing neurohumor. Hyperpathia, on the other 
hand, may result f~om the presence of bradykinin in the local 
area, which substance has been found to enhance the spike 
discharges of unmyelinated fibers (type C) (76). 
~-
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Since chemical mediation in inflammation has been 
postulated, it is expected that neurogram studies of experi-
mentally-induced inflammation would also predict the .involve-
ment of endogenous chemicals. Results in Figures 8 to 10 
have confirmed this. 
The neurogram recording studies of animals treated 
with ca:rrageenin indicated t.hat this inflammogen exhibited 
triphasic neurogenic activity (Figure 8). Several investi-
gators have stressed the considerable role that the prosta-
. glandins and bradykinins (other agents to a lesser degree) 
play in carrageenin-induced inflammation (92,103,104,105, 
106). The biphasic development of carrageenin edema in rats 
was first described by Vinegar et al. where the first phase 
i.s seen immediately after injection of the irritant and 
accelerates rapidly before tapering off between 20 and 60 
minutes after injection (107). The second phase begins one 
hour after injection and proceeds rapidly until the third 
hour when the edema begins to taper off. While Vinegar 
· et al. reported in a later paper that histamine and sero-
tonin (as well as bradykinin and the prostaglandins) were 
not the primary mediators in the inflammatory reaction, 
nevertheless phagocytic processes soon release these chemi-
cal substances into the exudate (92). Therefore, the first 
two phases of neurogenic inflammation as seen in Figure 8 
are most likely due to the release of histamine and serotonin 
from the mast cells. It also has been established via 
[: 
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radioactive studies that histamine release is highly ele-
vated in the early phase of c~frageenin-induced inflammation 
whereas prostaglandins E1 and 'E2 are elevated in the late 
phase of the inflammatory reaction (103). The latter agents 
appear to be associated with the highly accelerated secondary 
phase (up to 150 minutes) as shown in Figure 8 (106). Brady-
kinin also can be partially responsible for this second phase 
since prostaglandins are known to potentiate the effects of 
bradykinin (99). In comparison with the non-specific reac-
tion-threshold pressure studies (94), the present study shows 
a similar response curve. This indicates that the pressure 
reaction sensed by the rat parallels the neurogram activity 
of tibiotarsal nerve. Figure 17 depicts that there are no 
significant differences between the plethysmographic studies 
of carrageenin-induced edema and neurogram activities of 
' . . d d . fl t. 36 h . . d d carrageen1n-1n uce 1n amma 1on. T e carrageen1n-1n uce 
edema studies of Bailey, conducted in this laboratory; are 
also in general agreement with those o~ Winter and Plata-
ker (94). The low regression coefficients for both curves 
exhibited in Figure 17 are expected since the lines do ex-
hibit curvature. The parallelism possibly indicates a 
correlation in time for edema formation and neurogenic 
36
The raw data used for this analysis was obtained 
from Bailey (108). The regression lines depicted in the 
figures, the respective regression coefficients, and the 
testing of parallelism of the two response curves were cal-
culated using the methods of Goldstein (109). For an 
illustrative sample calculation, see Appendix A. 
,= 
Figure 17: Calculated lin~ar regression lines and a testing 
of_Earallelism between carrageenin-induced pedal 
edema volume chanqes and changes in tibiotarsal 
neural activities in carrageenin-treated animals. 
Pedal ede~a volume changes 
r = 0.63 
Tibiotarsal neural activity 
changes 
r = 0.42 
The calculated t value for testing parallelism is 0.40, 
which is less tlian the critical value of 1.67 at P = 0.10 
































































activity o~ tibiot~~s~l ne~ve in c~~~~geenin-induced in-
flanunation. 
Saline-induced pedal edema studies were conducted 
along ~rd th neurogram studies of saline-induced pedal inflarn-
mation. This was done to establish the validity of both 
experiments, ~· no changes from control times are evident 
~or the three-hour recordings (Tables II and VI). No sig-
ni~icant differences neurologically from -5 minute readings 
~~~~ pf>s~l:"_Y§sl_d_e§p.l_J:;e _th~ _introduction of the needle which __ 
was put in place approximately 30 minutes prior to the actual 
administration of saline into the hind paw (Table II) . How-
eve~ (see Table VI), a significant difference is apparent 
between +5 minutes and -5 minutes -- this can be attributed 
to the autonomic reflexes expected immediately after the 
administration of saline into the rat hind paw. 
Autonomic effects were also apparent within the first 
15 minutes in rats injected with brewer's yeast (Figure 9, 
T~bles II and III) • Part of the response noted is undoubtedly 
due to the larger volume (0.1 ml.) introduced into the paw. 
This is interestingly in agreement with the Winter and Flata-
ker report (94). Since no edema formation is formed in the 
presence of hyperesthesia (94), it can be assumed that the 
mechanism of edema formation is not analogous to the mechanism 
of neurogenic inflammation in yeast-induced inflammatory 
re~ction, Nevertheless, in one study dealing with the 
mechanism of yeast-induced edema (little edema formation 




possible selective major chemical mediator (96). This may 
mean that yeast is a non-specific inflammogen, i.e. yeast 
does not affect the events leading to the edema part of 
inflammatory reaction but may affect only the hyperalgesic 
component. In this case, chemical mediation of yeast-
induced inflammation may be ruled out even though the mech-
anism by which yeast acts on and in the nerve may indicate 
an upset in chemical balance. Yeast's poor phlogistic 
property in anti-inflammatory studies is also supported by 
the fact that indomethacin, at various dose levels, failed 
to reduce the edema but did reduce the pressure threshold 
at the time of the one-hour recording (94). 
Peak neurogram activity with dextran was reached 
90 minutes after the pedal injection (Figure 10) and the 
results are almost similar to the pressure threshold reac-
tion curve reported in Winter and Flataker's paper (94); 
however, the curvature in the latter repor·t is very small. 
While Figure 10 may demonstrate some hyperalgesic property, 
results of Winter and Flataker indicated'the significant 
degree of hypoalgesic activity of dextran. They also re-
ported that dextran at the dose level of 0.05 ml. of 1% 
solution failed to produce edema in the animals. Thus, 
the inflammatory mechanism may not be the same for dextran-
induced edema and hyper-(or hypo-)algesia. It was reported 
that the primary event in dextran shock is the formation and 
release of vasoactive agents such as bradykinin, histamine 
93 
and serotonin, which act directly on blood vessels leading 
to a leak of blood protein and fluid into the tissue spaces 
(110). It has also been reported that dextran inflammation 
does not depend on intact sensory nerve endings or upon in-
volvement of the axon refiex. Histamine alone cannot pos-
sibly be the mediator in dextran-induced inflammation and 
apparently histamine needs the participation of serotonin 
to produce dextran's full inflammatory effect (111). This 
is supported by the fact that the administration of cypro-
hepatadine (112), an agent with slight antihistamine and 
strong antiserotonin activities, can reduce dextran-induced 
edema. Mepyramine, a potent antihistaminic, does not reduce 
the edema significantly. The role of serotonin release dur-
ing dextran-induced inflammation is further supported by 
another study, where dextran was demonstrated to bind strongly 
to platelets (113). After tissue injury, platelets are known 
to aggregate, break down and release serotonin (6,14). Sicu-
teri et al. has reported that serotonin alone cannot pro-
duce pain but needs to be potentiated by bradykinin or its 
precursors to produce hyperalgesia (114). Therefore, the 
hyperalgesic effect seen in tibiotarsal nerve in a rat 
treated with dextran is most likely due to the presence of 
a high concentration of serotonin which, in turn, potentiates 
the bradykinin present in the plasma substrate. 
Winter has reported that of all the exudative models 
of inflammation, carrageenin-induced pedal edema is the least 
94 
susceptible to non-specific inhibition (91). On the basis 
of his work and of the neurogram studies of the inflammogens 
in the present study, it appears that carrageenin is the most 
suitable phlogistic agent to be employed for drug screening 
studies utilizing neurogram recordings of tibiotarsal nerves 
in rats pretreated with certain prototype anti-inflammatory 
agents. Since the time/effect course of carrageenin~induced 
pedal edema is analogous to the time/effect course of car-
rageenin-induced pedal neurograms, it was expected that the 
neurogram recordings in rats pretreated with anti-inflammatory 
agents would also correspond to the plethysmographic record-
ings of hind paws in rats treated with similar agents. It 
should be noted here that carrageenin-induced edema can be 
inhibited by the intraperitoneal administration of general 
irritants this suggests that anti-inflammatory agents 
shorild always be given orally so as to minimize this "counter-
irritative" effect (115,116). 
The mechanism of the inflammato.-ry reaction as well 
as the mechanism(s) of anti-inflammation have been greatly 
debated in the past few years -- especially with the advent 
of the prostaglandins. The mechanism of action of carra-
geenin-induced pedal inflammation continues to remain poorly 
delineated. Ferriera, who is an advocate of the hypothesis 
that prostaglandins play a significant role in inflammation, 
has said that he does not need to have a carrageenin animal 
model in order to have a deep and clear understanding of the 
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process of arthritis. He has emphasized the greater impor-
tance of understanding the mechanism(s) of anti-inflamma-
tory drug action (117). 37 
In comparing Figure 7 with Figure 11, one notices an 
almost total absence of type A nerve fiber spikes in Fig-
ure 11. Chahl and Iggo have reported that the potentiative 
effects of bradykinin in the presence of a low concentra-
tion of prostaglandin E1 will produce maximal type A spikes 
in neurogrruns of rat saphenous nerve (99). Lewis has pro-
posed that a histamine-like substance is released from dam-
aged cells to serve as a vasodilator mediator between anti-
dromically-activated type C fibers and blood vessels (47). 
However, this antidromic vasodilation cannot be blocked by 
antihistaminic agents (histamine is not a mediator at the 
end of axon reflex). It can, therefore, be concluded that 
phenylbutazone may inhibit prostaglandin E1 biosynthesis or 
bradykinin itself. Tables IV and V and Figure 12 indicate 
that the nadir. points in neurogram recordings were reached 
between 60 and 90 minutes after the pedal injection of 
carrageenin. Collier, in 1962, reported that aspirin and 
phenylbutazone are antagonists of kinin (118); however, 
several other papers have indicated that phenylbutazone is 
37This remark was made during the discussion follow-
ing Ferriera's presentation of a paper at "Future Trends in 
Inflammation. II. Proceedings of an International Meeting 






neither an inhibitor of prostaglandins nor of leukocyte 
migration into the inflammatory exudates (119,120,121). 
While phenylbutazone has been shown to inhibit prostaglandin 
biosynthesis in nine-hour sponge exudates in rats (96% inhi-
bition), there was compelling evidence that this had little, 
if any, correlation with anti-inflammatory activity in vivo 
as it was shown not to be affected by plasma fraction (119). 
This plasma fraction has been established to exert a wide 
variety of anti-inflammatory effects in animal models. One 
may argue that the course of time is very import.ant when 
considering such reports, since our results indicate hypo-
algesia between 60 and 90 minutes while the literature survey 
reported results at least 6 hours after the administration 
of phenylbutazone. 
Indomethacin appeared to exhibit the same type of 
hypoalgesic activity as phenylbutazone (Tables IV and V and 
Figure 13) although the former is more potent than the lat-
ter. Consequently, it would appear that indomethacin is a 
stronger inhibitor of prostaglandin E1 and/or bradykinin 
than phenylbutazone in a dose-to-dose relation. This greater 
I 
potency of indomethacin has been confirmed by Mills (122) 
apd others. The premise that indomethacin plays a role in 
inhibition of prostaglandin synthetase during carrageenin-
induced inflammation has been strengthened by several of 
Ferriera's papers (123) including one which measured prosta-
glandin release in dog knee joints (100). It should be 
noted that this paper admitted that pain receptors in 
different organs could have different susceptibility to 
prostaglandins E1 and E2 . In contrast to phenylbutazone, 
however, indomethacin does not affect the number of mono-
nuclear cells present in carrageenin-induced rat pleurisy 
(121) • 
It may be inferred that aspirin is not superior 
91 
to either phenylbutazone or indomethacin in its anti-inflam-
matory and analgesic properties. Tables IV and V and Fig-
ure 14 indicate that acetylsalicylic acid may not be as 
effective an analgesic as the other two at the doses tested. 
However, in Table V, the differences between the three anti-
inflammatory agents for the various time periods were not 
significant. Aspirin has been established to be an inhibi-
tor of prostaglandin biosynthesis (122), but the present 
data casts doubts on possible role that prostaglandins 
may play here. Collier (118) and Lim (70,71) have confirmed 
that aspirin inhibits the production of bradykinin periph-
erally. Morever, Lim has emphasized the chemoception of 
pain receptors and that these receptors are not nociceptors 
as claimed by other investigators (20). Furthermore, Lim 
has stated that aspirin acts peripherally by blocking the 
generation of impulses of the chemoreceptors for pain. 
Bonta et al. has argued that aspirin does not inhibit the 
biosynthesis of prostaglandins; evidence was presented that 






of aspirin in essential fatty acid deficient rats (124). 
Arachidonic acid, a precur~or of prostaglandin is an 
example of one of ·these essential fatty acids. However, it 
may be argued that prostaglandins may still be present in 
very low concentrations. 
A prototype anti-inflammatory corticosteroid, 
hydrocortisone, was employed in this study to determine 
whether it. has any neurogenic anti-inflammatory capacity. 
This agent has the ability to prevent or suppress the devel-
opment of local heat, redness, swelling and tenderness in 
an inflammatory reaction. It is not only effective in the 
early phase of inflammation but it also inhibits capillary 
and fibroblast proliferation in the later phase. However, 
hydrocortisone is indicated only for palliative therapy; 
i.e. it only suppresses inflammation. In comparison to 
the other anti-inflammatory agents discussed so far, hydro-
cortisone appears to be the least potent "analgesic" of the 
compounds tested (Tables IV and V, and Figure 15). In fact, 
one hour after carrageenin pedal injection, the curve rose 
to a level of hyperalgesia which is parallel to the control 
carrageenin-induced pedal infl"ammation (Figure 15). This 
would indicate that algesia is not inhibited in the pres-
ence of hydrocortisone and that chemical mediation does 
not play an important role in hydrocortisone's mechanism 
o-e action. 
De Cato e·t al. have reported the anti-inflammatory 
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effectiveness of orally administered chlorpromazine upon 
carrageenin-induced pedal edema (97). This agent, it was 
concluded by Arrigoni-Martelli et al. has its anti-inflam-
matory effect as a result of an inhibition of catecholamine 
uptake which in effect potentiates the local effects of 
these amines (125). Chang has suggested that chlorproma-
zine's antihistaminic, antiserotonin and antibradykinin 
activities were not responsible for the inhibition of 
carrageenin-induced pedal edema since cyproheptadine, a 
more potent inhibitor of these substances, was relatively 
inactive (126). The high degree of hypoalgesia in chlor-
promazine is very evident as in Figure 16~and Tables IV and 
v. This may be partly attributed to its central effects. 
Phenobarbital has been reported to suppress or abolish 
type C nerve potentials via the substantia gelatinosa where 
it facilitates the transmission of input from peripheral 
fibers to transmission cells thus permitting the maximal 
presynaptic and postsynaptic inhibition and reduction of 
the afferent barrage below the critical level necessary 
for pain to occur (53). For this reason, urethan which is 
known to possess hypnotic activity with no serviceable · 
ability for analgesic effect, was employed as an "anesthetic" 
in this study. It can be inferred, therefore, that urethan 
may then allow chlorpromazine to exert its own central 
nervous system effects. Willoughby and Spector have pro-
posed that catecholamines are endogenous anti-inflammatory 
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agents (127). Whether or not the catecholamines and 
prostaglandins play a role in the production of pain, the 
present study cannot determine. This question can only 
be solved by biochemical studies. 
It is of great interest to compare the neurogram 
activity of the anti-inflammatory agents tested with their 
antiedema activity against carrageenin-induced pedal edema. 
Figures 18 to 22 incorporate the studies of Bailey (108) 
with those of this investigator. All anti-inflammatory 
agents with the exception of hydrocortisone (Figure 18) 
exhibited significant differences between the edema forma-
tion and hyperalgesic activity in time-course studies. This 
indicates that different mechanisms of action occur for the 
two cardinal signs, edema and pain, in carrageenin-induced 
pedal inflammation. In other words, edema formation is 
produced via one specific mechanism whereas algesia results 
via another specific mechanism. Vinegar et al. have con-
eluded that edema formation is not the -result of inflammatory 
cell mobilization but, instead, is a consequence of cellular 
activity after mobilization (92). This cellular activity 
is most likely due to phagocytosis and cellular lysis. These 
workers have stated that histamine, serotonin, bradykinin, 
arachidonic acid and prostaglandins E1 and E2 are not respon-
sible for edema formation. Indomethacin, aspirin and phenyl-
butazone do not significantly decrease the number of mono-
nuclear cells in carrageenin-induced pleurisy (26,92). 
Figure '18. Calculated linear regressi~n lines and a 
testing of parallelism betv1een hydrocortisone-
pretreated car~eenin-induced pedal volume 
+-----------------------~c~=a=n=g=e==s==a=n=~anges in tiniotarsal neural 
actlvlties-rn-hvdrocortiSone-uretreated 
carrageenin-'induced inflarrunatlon. 
Pedal edema volu~e changes 
r = 0. 69 
Tibiotarsal neural activity changes 
r = 0. 27 
The calculated t value for testing parallelism is 0.255, 
which is less than the critical value of 1.67 at P = 0.10 




































































Figure 19. Calculated linear regression lines and a 
testing of 12a~all_eli~~~-!~een indomethacin-
pretreated carrageenin-induced pedal edema 
volume changes an'd changes in tibiotarsal 
neural a~vlties~n--indomethacin-pretreated 
carrageenin- inducedTri f 1 am mat i 0 n . 
Pedal edema volume changes 
r = 0.58 
Tibiotarsal neural activity 
changes 
r = 0.13 
The calculated t value for testing parallelism is 1.85, 
which is greater than the critical value of 1.67 at P = 
0.10 (equivalent toE= 0.05); d.f. - 66. 
0 
































































Figure 20. Calculated linear regression lines and a test-
ing 9__f_paralleli§m . .J?e!~een phen_yl_butazone-
pretrea ted c~rrageeni_!l-induc~d pedal edema 
volume changes and changes in tibiotarsal 
neural activities in. phenylbutazone-pi:etreated 
carrageenin-induced inflammation. ·------
Pedal edema volume changes 
r = 0.60 
Tibiotarsal neural activity 
changes 
r = 0.27 
The calculated t value for testing parallelism is 2.287, 
which is greater than the critical value of 1.67 at P = 











































































Figure 21. Calculated linea~~egre~sion lines and a 
testiny.,_.21._J2aral~el_t§m be_twe~-~-~cetylsa~i­
cyclic aci4.=.J2r~_!Eeated carra_geenin-induced 
pedal edem~-~QlU~~~a~ges and changes in 
tibiotarsal neural activities in acetylsali-
cyclic acid-pretreatedcarrageenin-induced 
inflammation. 
---------Pedal edema volume changes 
r = 0.73 
--- --- --- --- Tibiotarsal neural activity 
changes 
r = 0.63 
The calculated t value for testing parallelism is 4.167, 
which is greater than the critical value of 1.67 at P = 
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E.!.gure 22. Calculated linear re_gression lines and a 
testi~g of parallelism between chlorpromazine-
pretreated carragE:e~Tn-induced pedal edema 
volume changes anE changes in tibiotarsal 
neural activities in chlorpromazine-pretreated 
carrageenin-induced inflammation. 
Pedal edema volume changes 
r = 0.77 
-- -- -- --· Tibiotarsal neural activity 
changes 
r = 0.67 
The calculated t value for testing parallelism is 5.537, 
which is greater than the critical value of 1.67 at P = 
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Chlorpromazine is likely to act in the same manner as the 
others. 
Then, what does occur during neurogenic inflamma-
tion? In other words, what causes pain during an inflamma-
tory process? It is quite apparent that chemical mediation 
of some sort is responsibl,e for t.his property. It is well 
documented that histamine and serotonin are not inhibited 
by the anti-inflammatory agents used here. This leaves 
bradykinin and prostaglandins -- and possibly their pre-
cursors. Malone and Trottier reported that using isolated 
rat uterus, chlorpromazine was a competitive inhibitor of 
bradykinin while indomethacin exhibited non-competitive 
activity and phenylbutazone and calcium carbaspirin did not 
possess any anti-bradykinin activity (128). It is also 
well documented that acetylsalicylic acid, indomethacin and 
phenylbutazone (to some extent) inhibit prostaglandin bio-
synthesis. Since hydrocortisone is known for its non-
analgesic property, it is not surprising to see the signifi-
cant parallel relationship between edema formation and 
neurogram activity documented in the present study. This 
leads to the conclusion that hydrocortisone does not possess 
~ny anti-bradykinin and anti-prostaglandin properties per 
se. 
In summary, the inflammatory process is a myriad of 
complex mechanisms -- probably one specific mechanism for 
each of inflammation's five cardinal signs. Contrary to 
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many investigators' views, bradykinin and prostaglandins 
(and probably the catecholamines) all play individual roles 
as mediators of pain during inflammation. Perhaps only 
biochemical studies of the nerves themselves before and 
during an induced inflammatory reaction will define the 
specific mechanisms and their interrelationships. 
The neurogram recording technique devised by this 
investigator has been useful in providing insight into the 
complex processes of inflammation and anti-inflammation, but 
has not provided definitive answers. The techniques devel-
ped for this research can become routinei consequently the 
method can be used for screening of drug efficacy. The 
method described here is truly quantitative for inflamma-
tory neural activity ("pain") -- a parameter which has been 
unsuccessfully measured to date by others. The popular 
techniques presently used to screen for new anti-inflamma-
tory agents measure only the volume of induced edema while 
the pain component of inflammation is wholly ignored. To 
ignore one of the cardinal signs of inflammation during 
drug screening seems unwise. The method described here 
utilizes carrageenin, the most widely used edemogen, but 
also quantitatively measures neural activity associated 
with the area of induced edema. Consequently neural 
activity is measured directly and edema formation indi-
rectly. Further research studies incorporating the narcotic 
analgesics (morphine, meperidine), antihistaminics (di-
~-
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phenhydramine, tripelennamino), antiserotonergics (cypro-
heptadine, lysergic acid diethylamide) and other anti-
inflammatory prototypes (flufenamic acid, ibuprofen, cyro-
genine) should be conducted before the method is adopted 
for routine screening. Subsequent research incorporating 
this testing system should provide significant contribu-
tionsto our knowledge of both biochemical and neural mech-
anisms of pain induction and perception. 
CONCLUSIONS 
Pain is an important cardinal sign of inflammation. 
The mechan~sm by which pain is elicited during an inflam-
matory process has been poorly delineated. It is of prac-
tical and theoretical importance to determine if a new 
prototype anti-inflammatory agent possesses any hypoalgesic 
capacity as well as anti-edema, vasoconstricting and anti-
pyretic activities. 
While the analgesic activity of the common anti-
inflammatory agents have been well studied in the literature 
(~. the rat tail-flick test and the acidic writhing test), 
neurogram studies of nerves directly involved with the local 
inflammatory area have not been intensively studied in 
intact animals. Therefore, the first purpose of the present 
investigation was to determine if there were differences 
between the neurograms obtained in the presence of various 
known phlogistic agents. Results indicated that while there 
were no significant differences in time between the phlo-
gistic agents, each was significantly different from the 
saline control group. Carrageenin exhibited a triphasic 
neurogram activity curve (peaks at +30, 60 and 150 minutes 
after the pedal injection), whereas both brewer's yeast 
(peak at +120 minutes) and dextran {peak at +90 minutes) 
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exhibited monophasic curves. Dextran had the weakest hyper-
algesic activity while brewer's yeast and carrageenin had 
comparable degrees of hyperalgesia. 
In studies using a plethysmographic determination of 
pedal edema, carrageenin appeared significantly more edema-
tous than brewer's yeast as an inflammogen. On the basis 
of this observation and the results from the neurogram studies, 
the second phase of this investigation was to study neurogram 
recordings in the presence of prototype anti-inflammatory 
agents (carrageenin as the phlogistic agent). Results in-
dicated that chlorpromazine possessed the strongest hypo-
algesic activity while those animals pretreated with hydro-
cortisone demonstrated some hyperalgesia 90 minutes after 
the pedal injection of carrageenin. Phenylbutazone, indo-
methacin and acetylsalicylic acid had decreasing orders of 
hypoalgesic activity. 
Linear regression analyses were performed between 
plethysmographlc and neurogram recordings (effect/maximum 
effect} in agar control-, hydrocortisone-, acetylsalicylic 
acid-, indomethacin- and chlorpromazine-pretreated animals. 
There were significant parallel relationships in agar 
control- and hydrocortisone-pretreatedanimals whereas the 
other treatments were not characterized by parallelism 
between edema reduction and neurogram activity. Therefore, 
it is postulated that antidromic invasion of chemical medi-
ators plays an important role in neurogenic inflammation 
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(the production of pain) and that edema formation is a 
consequence of cellular activity (phagocytosis after 
mobilization). Hyperalgesic activity may depend upon the 
release of kinins from plasma substrate into the inflam-
matory exudate in the presence of low concentrations of 
prostaglandin E1 . Aspirin and indomethacin have been shown 
by others to inhibit the biosynthesis of prostaglandins. 
From the present study, it is predicted that phenylbuta-
zone and chlorpromazine may act in a similar manner. 
However, another chemical mediator may be responsible for 
phenylbutazone's and chlorpromazine's low hypoalgesic 
activity. 
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Sample calculation of linear regression analysis 
and test of parallelism between carrageenin-induced pedal 
edema volume changes and changes in tibiotarsal neural 
activities in carrageenin-treated animals. 
Group A (Edema volume changes expressed as effect ( m-a-x-i-rrn.l-m-e-f-f-e-e-t 
100)) 
Animal 
no. +5 minutes +1 hour +3 hours +5 
1 11 44 24 
2 8 55 73 
3 29 77 86 
4 12 56 74 
5 20 68 69 
6 15 ·44 80 
7 14 55 47 
8 14 61 86 
9 14 33 59 
10 23 58 100 
Total 
T (2,048) 160 551 698 
YA 

















T (5,853.380) 13.280 551 2,094 3,195 
T 2 
X A 
(350.069) 0.069 10 90 250 
T 2 (130,538) 2,912 31,785 53,024 42,817 y A 
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12.9 
Grou_E_!3 __ {_!_~biotars~!__n~:':!_ral activj:.!L cQ.ange:s expJ~ess_~d in 
effect 





















T 2 (100.069) 
X B 
T 2 (40,876) 
y B 
Calculation of Slope 
slope = b = 































































ss - 25,680.400 ss = 24,913 .. 867 
YA YB 
ss = 143.817 ss = 44.499 XA XB 
SP = 1,202.884 SP = 443.674 
xyA xyB 
bA = 8.364 .bB = 9.970 
ssx ss SP df=N-2 7 x-y , 
A 143.817 25,680.400 1,202.884 38 
B 44.499 24,913.867 443,674 28 
T 188.316 50,594.267 1,646.558 66 
Calculation of t value 
(T ) 2. 
SP 
u = xy 
(Note: larger minus smaller) 
Critical t with d.f. = 66 in a one-tail test (tabular value 
at P: 0.10 equivalent toP: 0.05) = 1.67. 
131 
Therefore, since calculated t is less than tabular !, the 
slope of edema volume changes curve is not significantly 
different from the slope of tibiotarsal neural activity 
changes curve. 
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